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Abstract
Convergent lines of research suggest there exists an excitatory cholinergic #
input to the substantia nigra from the pedunculopontine tegmental nucleus 
and possibly the laterodorsal tegmental nucleus. Previous work has f
suggested that microinjection of cholinergic agonists into substantia nigra 
elicits behaviours performed with a high frequency but with a low current 
rate (Winn 1991).
Experiments carried out during my PhD have demonstrated that:
Microinjection of cholinergic agonists to anterior substantia nigra (SN) 
elicited increased consumption of palatable food such as spaghetti but not 
rat maintenance diet in pre-satiated rats.
Stimulation of behaviour was achieved using direct agonists for either 
muscarinic or nicotinic cholinergic receptors (carbachol and nicotine 
respectively).
Stimulation of behaviour was also achieved using the indirect cholinergic 
agonist neostigmine which blocks the de-activation of endogenous 
acetylcholine by AChE.
Increased feeding elicited by cholinergic stimulation of the anterior SN 
was abolished by a selective lesion of ascending dopamine (DA) neurones 
which significantly depleted caudate DA levels but left accumbens DA 
levels unaltered.
A behaviourally potent dose of carbachol caused a significant increase in 
the response to different doses of nicotine suggesting an additive effect of 
muscarinic and nicotinic stimulation at the doses used.
■J
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îAdministration of cholinergic agonists to the VTA or SN caused
indistinguishable effects on responding for conditioned reinforcement. -M
#Cholinergic stimulation caused increased responding for a conditioned |
reinforcer and also reinstated responding at the primary reward source.
The functional significance of the cholinergic innervation of the DA- 
containing neurones of the substantia nigra is discussed with reference to 
its relationship to the neighbouring ventral tegmental area, and their . |
innervation of the caudate-putamen and the nucleus accumbens.
Cholinergic neurones in the PPTg and LDTN appear to exert a tonic 
control over the activity of midbrain DA-containing neurones. It is 
suggested that cholinergic control of midbrain DA-containing neurones 
facilitates the processing of information in the striatum and hence 
influence the selection of an appropriate behavioural response to a given 
situation.
1 The substantia nigra and midbrain dopamine systems 
Substantia nigra
The substantia nigra (SN) is a mesencephalic structure which lies on the 
cerebral peduncle, ventral to the zona incerta and medial lemniscus, 
lateral to the ventral tegmental area of Tsai (VTA), caudal to the 
entopeduncular nucleus, and rostral to the pedunculopontine tegmental 
nucleus (PPTg), The SN can be differentiated into two main areas; pars 
compacta (SNPC) and pars reticulata (SNPR), and a third area generally 
considered to be a subdivision of SNPR, the pars lateralis (Figure 1). The 
two major parts may be distinguished cyto-architectonically: the PC is 
cell-dense while the PR, although having a greater area, has relatively 
few neurones. The majority of neurones of the SNPR are relatively large 
(25-40 fx) and have 3-5 large dendrites confined to the SNPR. In contrast, 
the SNPC is densely populated by medium-sized neurones (15-20 fx) 
having 4-6 smaller dendrites which mostly branch down into the SNPR. 
A third type of neurone described in both the SNPC and SNPR is a 
smaller neurone (8-12 /*) having 4-6 smaller dendrites that appear to 
branch arbitrarily (Gulley and Smithberg 1971, Gulley and Wood 1971). 
The close association between SNPC and SNPR due to the descending 
dendrites of the SNPC neurones has made functional dissociation of the 
two areas difficult. An injection aimed at anterior SN is more likely to 
effect SNPC neurones than one aimed at posterior SN. However, an 
injection that has been shown by histology to have been placed in SNPR 
may well have affected the dendrites of the SNPC neurones.
Figure 1: Saggital view o f SN showing major projection areas
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The importance of SN in motor control is suggested behaviourally by its 
involvement in Parkinson's disease (PD), and anatomically by its 
reciprocal connections within the basal ganglia and also with various sites 
known to be involved in motor outflow (Figure 2).
Figure 2: Schematic view o f SN and projection sites involved in motor 
control
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The major efferent pathway of the SNPC innervates the largest 
component of the basal ganglia, the neostriatum. This structure is also 
referred to as the dorsal striatum, or as it will be referred to here the #
caudate-putamen (CP). The nigrostriatal pathway projects rostral and 
medial to the SN to become part of the medial forebrain bundle (MFB) 
which projects up to the telencephalon. Also forming part of the MFB are 
the dopaminergic fibres of the mesolimbic DA system. It is thus called as 
its targets are associated with behaviours such as learning and memory, 
emotion and motivation. These are thought to be controlled by the limbic 
system which includes the hippocampus and amygdala. The cell bodies of 
this system lie in the VTA and innervate, among other sites, the nucleus |
accumbens (NAcc) and the olfactory tubercule. The NAcc is the most 
intensely investigated structure in paleo- or ventral striatum. The fibres 
from the SNPC mainly innervate the ipsilateral CP. The CP projects back 
to the SN - the striatonigral pathway - innervating the SNPC forming 
what is thought to be (in part) a negative feedback loop to the 
dopaminergic neurones of SNPC. SNPR receives projections from the 
CP, the globus pallidus (GP), the subthalamic nuclei (STN) and the raphe 
nuclei. All of these structures are implicated in motor control or the 
etiology of diseases which effect motor control. In turn the SNPR 
innervates various nuclei involved in motor outflow: the diencephalic 
ventromedial thalamus, the mesencephalic superior colliculus and the 
PPTg.
SNPC dopamîne-contaînîng neurones
The nigrostriatal neurones of the SNPC contain the catecholamine 
dopamine (DA). DA was recognized as being a neurotransmitter 
independent of its role as a precursor to noradrenaline (NA) in the mid­
sixties due to the mismatch of its presence in certain tissues compared to 
tliat of NA. In the CP there is no measurable amount of NA but 
measurements of DA concentration had been made as long ago as the late 
1950's.
Figure 3: Biosynthesis pathway o f DA
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Figure 3 shows the steps of biosynthesis of DA. Tyrosine is one of the 
twenty amino acids that make up all mammalian proteins. As can be seen 
from Figure 3, the addition of an hydroxyl group (OH) converts it to 
DOPA. The enzyme which catalyses the hydroxylation of tyrosine is 
found only in catecholamine neurones. Tyrosine hydroxylase (TH) is 
extremely selective for tyrosine. The specificity of the enzyme and the 
localisation of the site to catecholamine neurones makes this the rate- 
limiting stq) of the process of catecholamine synthesis. The conversion of
f1
À
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sDOPA to DA is not localized to catecholamine neurones and the enzyme 
responsible, DOPA decarboxylase, will catalyse the decarboxylation of #
the precursors of histamine and serotonin as well. Hence the levels of 
DOPA in neurones is usually very low. DA neurones do not contain DA- 
beta-hydroxylase so the chain of catecholamine synthesis is not taken to 
its noradrenergic conclusion.
DA is taken up by neurones by a high affinity system where it is broken I
"Idown into metabolites by monoamine oxidase (MAO) and aldehyde "|j
dehydrogenase to DOPAC or by MAO catechol-O-methyl transferase and 
aldehyde dehydrogenase to HVA.
I
Electrical activity of DA neurones 
Chiodo (1987) has described the electrophysiological characteristics of 
DA neurones. The firing pattern is biphasic or triphasic; the first phase 
always being positive, with an action potential duration of 2-5 msec with 
peak-to-peak amplitudes of 0.5-1.5 mV. The firing pattern is either 
irregular with a single spike or burst-firing of 2-8 spikes of increasing 
duration and decreasing amplitude; there is a sharp decrease on the initial 
positive phase of the potential called the initial segment-somatodendritic 
break. The second phase of the action potential depends on the 
striatonigral pathway causing inhibitory post synaptic potentials from the |
somatodendritic parts of the DA neurones. Hence antidromic stimulation 
of DA neurones will only stimulate the first phase of the action potential.
The action potential of DA neurones consists of a large inward sodium 
current and smaller transient potassium and calcium currents. The 
formation of sodium-dependent somatic action potentials is also to a 
certain extent dependent on dendritic calcium currents which carry the 
slow depolarizations.
;
There exists common to all DA neurones what Chiodo describes as 
’pacemaker' activity. This is endogenous firing that occurs independently 
of any afferents to the neurones. The predominantly inhibitory afferents 
to tlie SNPC could then be seen to be restraining the DA neurones. The 
basal ganglia is described as being a system of inhibitory loops. Diseases 
associated with the basal ganglia have been seen as problems of 
disinhibition of the target zone of the particular pathway affected, for 
example, the DA nigrostriatal pathway in Parkinson's disease (PD) and 
the GABA striatonigral pathway in Huntington’s chorea.
Striatal influence on nigrostriatal DA release
Various proteins effect the activity of DA neurones in the SNPC. The 
release of DA is also affected by proteins in the CP.
Giorguieff et al. (1977) used rat striatal slices to perform biochemical 
analysis of DA release in response to various drugs introduced into the 
perfusing medium. By introducing tritiated tyrosine they were able to 
measure the release of newly synthesized DA. Tetrodotoxin (TTX) blocks 
voltage-sensitive Na*  ^ channels thus precluding the possibility of release 
by action potentials. Perfusion with TTX or with a Ca^"^-free medium 
significantly reduced the release of [^H]DA without affecting the rate of 
tyrosine hydroxylation. This shows that even without axonal action 
potentials, DA release is still dependent on normal neurotransmitter 
release mechanisms, i.e. is Na"^ channel and Ca^ "*" dependent. Also 
found to be Ca^*  ^ dependent was release of DA in response to ACh. An 
increase of about 100% was seen in response to 10"^  M ACh. This 
increase could be reduced significantly using the nicotinic cholinergic 
antagonist pempidine (10"^M) and also by the muscarinic cholinergic 
antagonist atropine (10“^ M). The reduction by using both blockers 
together was said by the authors "to approach significance". Neither
blocker significantly affected the spontaneous release of DA or its rate of 
synthesis when perfused without ACh. This would suggest that there are 
receptors on the presynaptic membranes of NSP DA neurones in the CP 
mediating cholinergic stimulation of DA release, and furthermore, that 
both nicotinic and muscarinic cholinergic receptors are present.
Gauchy et al. (1991) investigated the pre-synaptic control of DA release 
by ACh in the cat CP. The release of DA was increased by ACh and 
blocked by atropine suggesting it was mediated by activation of pre­
synaptic muscarinic receptors on NSP DA terminals. |
Many receptors have been shown to exist in various receptor subtypes.
This has b^n done on the basis of pharmacological attributes and also by 
molecular analysis in cloning studies. This has led to a degree of 
confusion as to which category of subtype is being referred to for a given 
receptor, making the literature quite intimidating. Weiner et al. (1990) 
refer to muscarinic receptor sub-types Ml, M2 and M3 on the basis of 
pharmacological data, and sub-types ml-m5 on the basis of molecular 
cloning studies. Weiner correlates them thus: Ml = ml, m4 and m5; M2 
= m2; and M3 = m3. Weiner et al. (1990) attempted to map the 
distribution of muscarinic and DA receptors in the basal ganglia. They 
used probes for the mRNA of the 5 muscarinic sub-types definW by 
molecular cloning studies, and also probes for the D2 receptor. No probe 
for the D1 receptor was available. The localisation of the messenger RNA 
for a certain receptor subtype is suggestive that the receptor itself is 
present at that location. To do this Weiner et al. prepared 
oligodeoxynucleotide probes. A nucleotide is a 'sub-unit' of a nucleic 
acid of which RNA and DNA are two examples. The units link from their 
phosphate group to the next unit's deoxyribose group to make the chain. 
As oligo just means little, Weiner's probes identify which mRNA is 
present by characterising the links between the subunits of the mRNA.
This they do by linking, hybridizing, with the mRNA present in the tissue 
being analysed. The probes were radioactively labelled so they would 
show up on the slices when incubated against photographic film. Three 
muscarinic receptor sub-types (ml, m2 and m4) and the D2 receptor were 
found in the CP. The ml mRNA was in >80% of striatal neurones, m2 
was rarely observed and then only in relatively large neurones, and the 
m4 and D2 were present in 40-50%, one third of which expressed both 
m4 and D2 mRNAs. All of the neurones which expressed the D2 mRNA 
also expressed the ml mRNA. The expression of mRNAs was observed 
to have gradients through the structure. D2 and m4 mRNAs were 
observed to have a medial to lateral gradient, while ml had the reverse. 
Effectively all SNPC neurones expressed both the m5 and D2 mRNA. 
This is probably partly due to only the medial part of the structure being 
analysed. The only other structure in the basal ganglia to express 
muscarinic mRNAs was the STN which expressed m3 and m4. The 
entopeduncular nucleus did not express any of the receptor mRNA. The 
morphology of the neurones which expressed the m2 mRNA in the CP 
make it likely that they are cholinergic intemeurones. As it was only the 
m5 mRNA expressed in the SNPC it seems likely that muscarinic 
cholinergic activation of SNPC neurones is mediated by m5 receptors. 
This further classification of muscarinic receptors may eventually explain 
its ability to have opposite effects on the same neuronal system. The 
antiparkinsonian drug trihexyphenidyl is reported by Weiner to have a 
stronger antagonistic effect on ml and m4 receptors than on m2, m3 or 
m5. It seems likely that its action is in the CP rather than the SNPC 
where presumably it would inhibit DA release by antagonising m5 
receptors on NSP neurones. However, ml and m4 receptors are co­
localized with D2 receptors in the CP, and D2 agonists decrease DA 
release. It would seem then that the anti parkinsonian effects of
muscarinic antagonists have their effects on the CP in the same area as, f
'-I:and having opposing effects to, D2 receptors.
The excitatory amino acid glutamate innervates the CP from the |
overlying neocortex. Romo et al. (1986) have demonstrated that the 
terminals of NSP DA neurones release DA in response to stimulation by 
glutamate. Glutamate has a prescribed excitatory influence on seemingly 
all CNS neurones.
Dynorphin is an opioid peptide. It has various pharmacological effects 
depending on which of the three opioid receptor sub-types (delta, kappa 
or mu) it is activating. Gauchy et al. (1991) have produced evidence for 
the localisation of kappa opioid receptoirs presynaptically on NSP DA in 
the CP. Both dynorphin and a specific kappa agonist attenuated the 
release of NSP DA by ACh, and this effect was blocked by the dynorphin 
antagonist naxolene. TTX blocks the conduction of action potential in a 
neurone without affecting the resting membrane potential. Thus it 
effectively blocks any effects that may be caused indirectly by, for 
example, interneurones, as the intemeurone membrane will not be able to 
achieve the increase in sodium conductance associated with axonal 
propagation of an action potential. The effects of dynorphin on ACh- 
evoked DA release were observed in the presence of TTX, therefore the 
site of action was probably the DA terminals of the NSP neurones.
Nigrostriatal DA influence on the caudate-putamen 
The presence of the catabolic enzymes for ACh and DA in adjacent cells 
observed to make synaptic contact would be suggestive of a cholinergic- 4
dopaminergic interaction. Kubota et al. (1987) used electron microscopy 3
I(EM) combined with choline acetyltransferase (ChAT) and TH 
immunoreactivity to investigate DA-ACh synaptic contact in the CP. 5- 1
8% of striatal neurones were observed to be reacting positively to the
10 ^
■i
ChAT stain, the striatal cholinergic 'type I' neurones. When adjacent 
slices were stained for TH it was shown that the position of unstained |
cells adjacent to TH-positive cells correlated with 85% of the ChAT- 
positive cells. An interwoven network of smooth, unmyelinated TH-
Spositive fibres were observed all throughout the CP. The membranes 
were seen using EM to have symmetrical synaptic specializations. ; 1
Pickel and Chan (1991) used ChAT immunohistochemistry and EM to 
determine how non-cholinergic neurones made contact with the ACh 
interneurones. As well as direct synaptic contacts between unlabelled 
terminals and ACh neurones they also observed 'appositions’, contacts
between ACh and non-ACh neuronal membranes, without the usual
intervening astrocytes. These appositions showed electron densities 
associated with synaptic contact but without the ultrastructural features j
associated with classical synaptic contact. It is unclear from this study as 4
to the neurotransmitter contained within the neurones contacting the ACh #
neurones. It is likely however that the non-ACh neurones would be DA,
GABA, glutamate or a combination of afferent fibres.
It was suggested by Rolls et al. (1984) that the role of DA might be to 
increase the efficacy of other neurotransmitters in the striatum. This could 
explain the apparently contradictory actions of DA as being excitatory, 
inhibitory and in some papers, both. Chiodo and Berger (1986) 
iontophoretically introduced the excitatory amino acid glutamate and the 
inhibitory amino acid GABA to striatal type I neurones and then observed 
the effect of exogenous DA. DA on its own had an inhibitory effect on 
any neurones that responded. Glutamate increased cell firing. When 
applied at a relatively low current (small amount released), DA enhanced 
the increased firing in response to glutamate, but when applied using a 
higher current, response to glutamate was attenuated by 50%. Both of 
these effects were blocked by the DA receptor antagonist trifluoperizine.
i
11 ' I3
GABA inhibited firing of all striatal type I neurones tested. At a 
concentration that by itself had no affect on the firing rate, DA enhanced '
'■■Jthe inhibition of GABA. When used at a higher concentration DA still #
enhanced the inhibition of GABA. These effects were also blocked by the 
DA antagonist trifluoperizine. It would appear that DA does enhance the Ieffects of other neurotransmitters on type I neurones in the CP and that 
this enhancement is dose-dependent.
It appears that DA released by NSP terminals effects not the nature of 
other striatal afferents to the striatum, but does modulate their effect at 4 'II
their target type I neurones. That is to say, DA is affecting the
'bandwidth' of response by the striatal neurones rather than their 'tuning'.
It follows then that an event tliat is supposed to increase NSP DA release, 
such as tail-pinch, should elicit a modulation of striatal type I neurone |
behaviour that is measurable using electrophysiological techniques.
De Keyser et al. (1988) used tritiated SCH 23390 and spiroperidol to 
label D1 and D2 receptors respectively in the human brain. They found 
high densities of both receptor sub-type in the caudate and putamen 
nucleus (the structures are physically separated in the human), and the 
NAcc. Both types of DA receptor were also present in the SN.
Characterisation of the relationship between the two sub-types of DA 
receptors has been made possible with the development of selective 
agonists. Kelland et al. (1988) used single-unit recording techniques to 
measure the effect of intravenous (i.v.) D1 agonist SKF 38393 on the 
inhibition of NSP DA neurones by i.v. D2 agonist quinpirole (LY ï
171555). They discovered that quinpirole was less effective at inhibiting 
'fast' DA neurones than 'slow' DA neurones. This is thought to be due to 
there being less somatodendritic autoreceptors on 'fast' neurones. An 
autoreceptor is activated by the neurotransmitter that the neurone on j
which it is located releases. This differentiation was blocked by
12
pretreatment with SKF 38393 giving the slow population the same dose- 
response curve to quinpirole as the fast cells. Furthermore this effect of 
the D1 agonist could be blocked by administration of the D1 antagonist 
SCH 23390 or by transecting the forebrain and hence cutting the 
striatonigral pathway. Such a transection had no effect on the rate- 
dependent response of NSP DA neurones to quinpirole. This suggests that 
the effects of the D2 agonist are localized to SN rather than the CP, but 
the alteration of the effects of D2 stimulation are mediated by the 
striatonigral pathway and hence is mediated by D1 receptors in the CP. It 
is unclear which neuronal population is mediating the effects of D2 
receptor stimulation on SN. It has no effect on the response of fast SNPC 
neurones to D1 agonists. In tlie same study they showed it also had no 
effect on the mesolimbic DA neurones of the VTA. It could be that the 
D2 receptive neurones of the CP are projecting selectively to the slow 
NSP DA neurones. It would be interesting to know in the light of Chiodo 
and Berger study (1986, see above) whether the effect of the D2 agonist 
would be to increase instead of decrease the difference between fast and 
slow NSP DA neurones if administered at a different dose. As the effect 
of the CP D2 receptor stimulation is to decrease the inhibitory effects of 
SNPC D1 receptor stimulation, NSP DA is effecting striatonigral 
neurones in such a manner as to increase the probability of firing of NSP 
DA neurones.
The release of DA in the striatum is causing the gating of slow SN DA 
neurones to be less responsive to inhibition by the release of DA by itself 
and its neighbouring cells. This puts a different perspective on the 
possible role of the lateral inhibition, or indeed, lateral stimulation with 
respect to the function of dendritic release of DA. Whether they release 
DA onto neighbouring neurones or not, they are not leaking onto 
receptors on a passive membrane, but a neurone whose responses depends
13
on its own state. It would appear we have not only lateral inhibition / 
excitation in the DA NSP neurones but potentially negative / positive 
feedback as well.
50 out 53 NSP DA neurones tested by Kelland et al. (1989) were 
inhibited by electrical stimulation of the sciatic nerve. This inhibition is 
still present following sectioning of the striatonigral pathway. Inhibition is 
increased by i.v. administration of the D1 agonist SKF 38393. This 
enhancement was reversed by the selective D1 antagonist SCH 23390, 
and blocked by sectioning the nigrostriatal pathway. The selective D2 
antagonist 1-sulpiride had no significant affect on response to sciatic nerve 
stimulation following administration of SKF 38393. This suggests that the 
NSP DA neurones are affected in a predictable manner by peripheral 
information. Furthermore the response of NSP DA neurones to such 
information is influenced by D1 receptors in the CP. The influence 
mediated by D1 receptors can increase or decrease NSP DA neurone 
response to peripheral information; the D1 antagonist reversed the effect 
of the D1 agonist, rather than just attenuate it.
There is obviously a body of evidence for a functional role for the D2 
receptor in the CP and a functional role for D1 receptors in the SN. 
However, De Keyser et al. localized both type of DA receptors to both 
the CP and the SN in the human brain.
Bannon et al. (1989) were interested in the effect of DA receptor 
activation and the levels of enkephalin peptides in the CP. In particular 
they were interested in the response to an increase in the level of DA on 
the preproenkephalin (PPE) and preprotachykinin (PPT) mRNA levels. 
The MFB was stimulated at 10 Hz which is above normal for NSP 
neurones but of a level that does occur in individual neurones when 
highly stimulated (Chiodo 1988). DA release was seen to be significantly 
elevated in the ipsilateral olfactory tubercule as was levels of PPE mRNA
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in the ipsilateral CP. Striatal levels of PPT mRNA were unaffected. 
Elevated levels of PPB mRNA were also produced by the systemic 
administration of indirect DA agonist methamphetamine and also by the 
selective D2 agonist quinpirole but not by the selective D1 agonist SKF 
38393. Given that previous studies have indicated that D1 receptor 
agonists do affect enkephalin synthesis, Bannon et al. concluded that the 
D1 receptors are already saturated in this study, suggesting that it is the 
D2 receptor that is responsive to supranormal levels of DA in the CP. It 
could be that the D2 receptor is an index of supranormal stimulation for 
tlie CP but it is not obvious from this study.
From such studies it appears that NSP DA neurones are projecting to 
among other targets, cholinergic intemeurones of the CP. Ajima et al. 
(1989) used microdialysis combined with HPLC and electrochemical 
detection techniques to monitor striatal ACh and DA release in free- 
moving rats. This technique also allowed them to introduce exogenous 
proteins into the area being studied. The D1 receptor agonist SKF 38393 
dose-dependently increased striatal ACh release (dose range 10"  ^ M to 
10"  ^M). Highest increase was 150% of basal levels in response to 3 x 
10“^  M SKF 38393. This increase appeared during the first hour and was 
still significant during the 3 hr post-injection period which was presented. 
DA levels quickly increased peaking at 500% of basal levels 1 hour after 
administration of 10"  ^ M SKF 38393. The D1 antagonist SCH 23390 
dose-dependently increased (10 M) or decreased (10'^ M) ACh release. 
The D1 antagonist had the same effect on DA levels as the D1 agonist. 
Injection of both the agonist and the antagonist together produced no 
significant effect on ACh level, but produced additive effects on DA 
levels. The authors then used D2 receptor agonists and antagonists. 
Neither sulpiride (D2 antagonist) nor LY 171555 (D2 agonist) had a 
significant effect on ACh levels in the striatum. The D2 agonist did
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attenuate the increase in ACh levels induced by the D1 agonist SKF 
38393. On its own, LY 17155 significantly decreased DA release by 
50%, but when administered with SKF 38393 DA levels were increased 
beyond that elicited by SKF 38393 alone.
These data suggest that both D1 agonists and antagonists can elicit 
increased release of ACh from striatal neurones, though higher doses of 
the antagonist decreases striatal ACh. That both agonist and antagonist 
produce the same effect on a neurone, and that this same effect is blocked 
by their coadministration would appear to support a modulatory role for 
DA D1 receptors in the CP as discussed above (Chiodo and Berger 1986). 
Ajima et al. however, talk of effects on intervening intemeurones to 
explain the effects. The role of the D2 receptor is still unclear. Its 
activation by agonists or antagonists had very little effect on ACh levels. 
Its lack of effect could have three not necessarily mutually exclusive 
possible explanations: firstly that D2 receptor activation does effect 
striatal ACh levels and the dose used was at the crossing point between 
excitation and inhibition of release, secondly that there are no post- 
synaptic D2 receptors on ACh neurones, or thirdly that the D2 receptor is 
tied to the D1 receptor for its effects and has no observable effects if 
activated independently. Ajima et al. report findings for only one dose of 
the D2 drugs. Ohno et al. (1987) have provided evidence for the presence 
of both D1 and D2 receptors on the same CP neurones though it has not 
been resolved as to whether this is the case for ACh striatal neurones. The 
D2 agonist certainly appears to have had an effect when used in 
conjunction with the D1 agonist SKF 38393. This might suggest that the 
third explanation of the D2 results is more likely.
The D2 agonist caused a significant decrease in striatal DA, arguing for 
a role as a pre-synaptic autoreceptor inhibiting DA terminals. It seems 
likely that the 'little' effect on ACh level by D2 activity alone is a result
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of its effect on DA release from NSP terminals. If Bannon et ai. (1989)
(see above) are correct concerning their suggestion that the D2 receptors 
in the CP function when DA release is at a supranormal level where D1 |
receptors are saturated, this might explain why Ajima et al. have found 
little response to their doses of D2 drugs.
Using oligonucleotide probes in a technique similar to that described by 
Weiner et al. (1990, see above), and retrograde labelling by infusion of 
fluorogold into the SN, Gerfen et al. (1990) mapped the expression of the 
genes for D1 and D2 receptor subtypes in the CP. D1 and D2 mRNA 
were localised to the striatonigral and striatopallidal medium spiny 
GABA-containing neurones respectively that make up the majority of CP 
cells. 43% of CP neurones were striatonigral, and of these 149 out of 173 
expressed D1 receptors while only 27 out of 184 cells that expressed D2 
receptors were labelled as striatonigral cells. The authors assumed that the 
remaining cells were striatopallidal. Furthermore, the striatonigral 
neurones expressed the neuropeptides dynorphin and SP while the 
striatopallidal neurones expressed enkephalin. Surmeier et al. (1992) "
provided evidence that D2 receptors are also localised to striatonigral 
neurones. This appears to be in disagreement with Gerfen's broad j
conclusions but cannot be ruled out on the basis of his studies. Figure 4 
provides a simplified summary of how DA and muscarinic receptors are 
thought to relate to striatal outflow neurones.
■. . .  f ■ ■.... ■
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Figure 4: DA and muscarinic receptor sub-types on striatal neurones
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The patches and matrices of the caudate-putamen 
The existence and possible roles of DA recq)tors in the CP have been 
discussed with reference to their localisation within the CP, It has become 
apparent over the last decade that the afferent and efferent neurones of the 
CP are not homogeneous in their distributicm. The CP has been 
subdivided into patch (or striosome, depending on the author) and matrix 
on the basis of the neurochemical content of these areas. The patches are 
known to have low levels of AChE (Graybiel and Ragsdale 1978) in the 
adult mammal and high density in infancy. The matrix areas show the 
opposite developmental histochemistry. DA receptors also display a 
heterogeneous distribution. D1 receptors show a higher binding in the 
patch than in the matrix (Besson et al. 1988), while post-synaptic D2 
receptor binding is higher in the matrix.
I
;s
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In an investigation of glutamate NMDA receptors by Krebs et al. (1991) 
DA release from NSP DA terminals was increased by administration of 
50 uM NMDA, The patches of the CP contain u-opiate receptors while 
the matrix areas do not. To compare the effects of NMDA on the two 
areas slices of the CP can be incubated with tritiated naxolene, a specific 
ligand for u-opiate receptors. Autoradiography then reveals which parts of 
the CP are patch and which matrix. DA release was significantly greater 
from the matrix than the patch area. TTX was used to investigate whether 
the increase in CP DA levels was due to direct activation of release from 
DA NSP terminals, or indirect through activation of neurones stimulating 
the NSP neurones at the SN. The NMDA-evoked release of DA from the 
matrix areas was significantly reduced, while release from patch areas 
was unaffected by local administration of TTX. There was no significant 
difference in the level of NMDA-evoked release of DA between the two 
CP compartments following TTX. It appears then that the greater release 
of DA from the matrix is due to other neurones, possibly striatonigral, 
synapsing onto DA NSP neurones.
Gauchy et al. (1991) found that spontaneous release of DA was
significantly higher in the matrix than in the patch areas of the CP. %
Furthermore, the release of DA was increased in both compartments by 
ACh. In the matrix area there was a significant inhibition of ACh-evoked 
DA release by TTX.
Using quantitative receptor autoradiography, Lowenstein et al. (1990) 
mapped the binding of tritiated pre-synaptic markers for dopaminergic 
and cholinergic neurones, and also Ml muscarinic receptors in the human 
brain. The binding site density for [^H] hemicholinium-3, a ligand that 
marks the high-affinity sodium reuptake mechanism of DA neurones, 
showed significantly higher binding in the matrix areas of the caudate, the 
putamen and the NAcc. The same was generally true for the distribution
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of [^H] mazindol, the pre-synaptic cholinergic neurone marker, and also 
for [^H] pirenzepine which labels Ml receptors. For all three markers, 
the density in the matrices was approximately twice that of the patches. 
This demonstrates a significantly higher incidence of cholinergic 
neurones, Ml-cholinoceptive neurones and DA terminals in the matrices 
of the three main areas of the human striatum.
Gerfen (1992) has proposed a model of how limbic and non-limbic 
information may be distributed from allocortical and neocortical sites in 
relation to cortico-strio-pallido-nigral connections (Figure 5).
Figure 5: Limbic and non-limbic cortical outflow and the basal ganglia
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It has been proposed by Gerfen (1989) that the patches of the dorsal 
striatum conveys ’limbic' information more normally associated with tlie 
ventral striatum (primarily the NAcc), and that the matrices of the ventral 
striatum conveys 'non-limbic* information more normally associated with 
dorsal striatal function. Furthermore Gerfen proposes that the limbic 
circuitry dominates in the ventral striatum, while the non-limbic circuitry 
dominates the dorsal striatum. Therefore direct administration of DA- 
ergic agonists into the NAcc will produce limbic behaviour, while DA- 
ergic stimulation of the CP will produce non-limbic behaviour.
Midbrain DA and behaviour 
The innervation of the CP and NAcc by midbrain DA- containing 
neurones of the SNPC (A9) and the adjacent VTA (A 10) respectively, has 
been extensively studied with respect to the initiation, selection and 
control of behavioural response. The methods employed include specific 
depletion of DA from the target structure and then ascription of function 
based on resultant behavioural abilities and inabilities, and more recently 
developed technology such as in vivo voltammetry whereby DA levels can 
be measured with a high temporal and neurochemical resolution in an 
unanaesthetised and hence behaving animal.
MesoUmbic DA and behaviour 
Infusion of DA agonists directly into the NAcc has been shown to 
produce different behavioural under different test conditions. Costall and 
Naylor (1975) observed increased locomotion following infusion of DA 
into the NAcc. Increased locomotion following systemic administration of 
amphetamine was blocked by a 6-OHDA lesion of the NAcc but not a 
lesion of the CP (Kelly et al. 1975). Furthermore, the direct DA agonist 
apomorphine significantly increased locomotor activity in rats with an
21
NAcc DA depletion but not in those with a CP DA deletion. This is 
thought to be due to supersensitivity of tlie striatal DA receptors as a 
compensatory mechanism for the loss of DA terminals in that area. 
Mesolimbic DA has also been intensely studied in the reinforcement of 
behaviours and as a neural substrate of reward (Fibiger and Phillips 
1986). Electrical stimulation of certain sites in the brain reinforced the 
performance of a behaviour paired with such stimulation (Olds and Fobes 
1981). These sites correlated well with the source and terminal fields of 
the midbrain DA systems including the VTA, SN, NAcc, CP, olfactory 
tubercule and prefrontal cortex. Both the mesolimbic and nigrostriatal 
pathway project rostrally forming part of the MFB. Electrical stimulation 
of this bundle will also reinforce behaviour. The reinforcing effect is 
attenuated by the local administration of a DA receptor antagonist into the 
NAcc (Stellar et al. 1983).
Fibiger et al. (1987) demonstrated that an animal trained to press a lever 
to self-administer electrical current to an electrode placed unilaterally in 
the VTA - intra-cranial self-stimulation (ICSS) - will cease pressing 
following an ipsilateral, but not contralateral, 6-OHDA lesion of the MFB 
causing a near total depletion of NAcc DA.
The rewarding effects of drugs of addiction such as cocaine and 
amphetamine are thought to be mediated by the mesolimbic DA system. 
Cocaine blocks the reuptake of DA hence prolonging its action at DA 
receptors. Amphetamine also blocks the reuptake of DA but also causes 
its release from DA-containing terminals. Roberts and Zito (1987) have 
shown that self-administration of cocaine or amphetamine is blocked by 
infusion of DA antagonists into the NAcc.
Carr and White (1983) were also interested in the neural substrates 
underlying reward. They used conditioned place preference (CPP), a 
technique whereby the subject, over a series of sessions, associates one
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environment with the tai'get drug and another with just saline. It was 
shown that when given a choice between the environment in which they 
had received amphetamine to another environment, those rats that 
received amphetamine injections into the NAcc displayed CPP but those 
having received amphetamine into the CP did not. The advantage of this 
paradigm is tliat the animal receives injections only during the training; in 
the test sessions the animal only has to express its preference for an 
environment. This removes any confounding effects of activational or 
stressful effects of the administration of a drug before a trial.
Taylor and Robbins (1984) demonstrated that a rat will find a previously 
neutral stimulus reinforcing if associated repeatedly with a primary 
reinforcer. They trained thirsty rats in operant chambers to associate the 
presentation of a compound stimulus (house light off, panel light on, and 
the sound of a server mechanism) with the presentation of water. The rats 
responding on a lever that would result in the presentation of the 
compound stimulus alone with no presentation of water, a second lever 
that had no programmed consequence, and responding on the water tray 
panel were recorded following bilateral infusions of doses of d- 
amphetamine to the NAcc, CP or the medio-dorsal thalamus. Taylor and 
Robbins observed clearly increased responding for the conditioned 
reinforcer following injections to the NAcc, ambiguous effects from the 
CP, and no effect from the medio-dorsal thalamus. The authors suggested 
that the results from CP injections may have been due to diffusion to the 
NAcc rather than due to a CP effect. In a second experiment in the same 
paper, Taylor and Robbins (1984) showed that the compound stimulus 
had to be correlated positively with the primary reward for there to be an 
increase in responding following NAcc injections of d-amphetamine. This 
they achieved by having three conditions during training: positive, 
whereby the compound stimulus immediately preceded the presentation of
%*
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water; negative whereby the compound stimulus came after the I
presentation; and random whereby the two events were uncorrelated.
In a follow-up study, Taylor and Robbins (1986) further delineated the 
reinforcing effects of DA-ergic agonists by showing attenuation of 
increased responding for a conditioned reinforcer following intra-NAcc d- 
amphetamine by 6-OHDA lesion of NAcc, but not by a similar depletion 
of CP DA. Furthermore, systemic administration of the direct DA agonist 
apomorphine increased responding in rats with an NAcc lesion but not 
those with a CP lesion. This led the authors to conclude that the increase 
in responding in those rats with an NAcc 6-OHDA lesion was due to the 
development of supersensitivity in the DA receptor sites following the 
loss of DA terminals.
Increased responding for conditioned reinforcement has also been 
demonstrated using food as a primary reward in hungry rats (Kelley and 
Delfs 1991). Similarly to the findings of Taylor and Robbins (1984),
Kelley and Delfs found increased responding following injections of d- 
amphetamine into the NAcc, but ambiguous results from the CP.
A hungry rat that is allowed free access to water but only allowed one 
pellet of food every minute will drink much more water than a rat that is 
allowed the same amount of food without having to wait between pellets.
Schedule-induced polydipsia (SIP) is believed to be an adjunctive 
behaviour, that is the rat is drinking because it is thwarted from its 
preferred activity, eating. Robbins and Koob (1980) demonstrated the 
relevance of mesolimbic DA to the acquisition of SEP by blocking it with 
a 6-OHDA lesion of the NAcc. The lesion did not impair the rat's ability 
to drink, nor does such a lesion impair the rat's ability to consume the 
pellets (Salamone 1988). |
Although the evidence would seem to suggest a role for the ascending * |
DA-containing neurones of the mesolimbic DA system as the neural d
3
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substrate for reward, Bielajew and Shizgal (1986) have shown that the 
reinforcing effects of electrical stimulation of the MFB is mediated by 
descending fibres, not ascending. Bielajew and Shizgal placed two 
electrodes in the rat brain, one in the MFB and one in the VTA. Each rat 
was allowed to, and did, lever press in order to receive electrical 
stimulation of the MFB and VTA. This demonstrated that the electrode 
sites could indeed support ICSS. They compared four conditions: using 
the MFB electrode as a cathode (-) with a skull screw or the VTA 
electrode as the anode (4-); and the VTA electrode as the cathode with a 
skull screw or the MFB electrode as the anode. If an hyperpolarizing 
(inhibitory) current is applied to an axon an action potential will be 
attenuated and if the current is sufficiently large, blocked. They found 
that action potentials were blocked most effectively by using the MFB as 
the cathode rather than the VTA. As the ICSS was more efficiently 
blocked by the anodal hyperpolarization of the VTA, this suggests the 
action potential was running from the MFB toward the VTA. This 
suggests that the fibres being affected descend from MFB to VTA, rather 
than VTA to MFB. That the fibres that support ICSS are in fact 
descending rather than ascending means that the crucial fibres cannot be 
the ascending DA-containing neurones of the mesolimbic DA system. As 
discussed by Bielajew and Shizgal, their studies do not elucidate further 
the source nor the destination of these ICSS-supporting neurones further 
than their source being rostral or at the MFB electrode site and their 
terminals being at caudal or in the VTA. Although this study 
demonstrates that ICSS is not directly affecting mesolimbic DA neurones, 
there is still a great weight of evidence to support their involvement in 
reward-related behaviours.
The Bielajew and Shizgal study leaves unanswered whether the 
descending ICSS-supporting neurones might arise from the NAcc and
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have their behaviour influenced by mesolimbic DA, or project to the 
VTA and influence the activity of DA-containing neurones in the VTA, |
or both, or indeed neither. What is does demonstrate is that ascribing 3
psychological constructs such as reward to one pathway is to oversimplify 
the relationship between behaviour and brain function, and that a fuller 
picture of how the brain influences behaviour must be approached at a 
systems rather than a single structure level*
Nigrostriatal DA and behaviour
High doses of amphetamine (for example, 5 mg / kg) produce repetitive 
behaviours tliat seem to have no goal - stereotyped behaviour. Although 
clearly such a construct as stereotyped behaviour is problematic in its 
definition and hence its quantification, rating scales have been developed 
to try to characterise the behaviours involved. The rating scale of Creese 
and Iversen (1973) as used by Kelly et al. (1975) rates the intensity and 
location of stereotyped behaviour but does not clearly demonstrate what 
constitutes stereotypy.
Kelly et al. (1975) showed that 6-OHDA lesion of the CP but not the 
NAcc blocked stereotyped biting, licking and gnawing following systemic 
administration of a high dose of the indirect agonist amphetamine.
Furthermore, the direct agonist apomorphine caused increased 
stereotyping in the rats with a CP lesion.
Kelley et al. (1988) demonstrated that specific orofacial stereotypies of 
licking, biting and self-injurious gnawing can be produced by injecting d- 
amphetamine into the ventrolateral CP, while the same doses injected to 
the posterior dorsal CP produced no effect on behaviour.
Lyon and Robbins (1975) proposed a theory characterising the effects of 
amphetamine on behaviour. The behaviour that a rat performed following 
administration of amphetamine was described as a function of the
.1
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complexity of the behaviour. With increasing dose, the chains of 
behaviours tliat could be performed become less complex (for example, 
eating > locomotion > sniffing) until with higher doses the animal can 
only perform behaviours that can be repeated rapidly and have a short 
time of completion.
The role of nigrostriatal DA in the control of behaviour is probably most 
clearly suggested by the debilitating effect of its absence in the 
progressive neurodegenerative disorder PD, The clinical relevance of the 
substantia nigra was realised during post-mortem inspection of the brains 
of people known to have been suffering from PD. The depigmentation of 
the tissue due to the loss of the melanised neurones was described and 
quantified by Homykiewicz (1960) who estimated DA depletions in the 
region of 80 and 90% in the caudate and the SN, respectively. Die 
difficulty in initiation and cessation of voluntary movements in PD is 
thought to result directly from the loss of the DA influence on the 
striatum. The tremor and rigidity that are the classic symptoms of PD are 
thought to not be a direct result of dysfunction in the NSP DA system per 
se. These symptoms are thought to be due to abnormal activity in the 
ventromedial thalamus, an output target for the CP known to be involved 
in motor control through its connections with the motor cortex and the 
basal ganglia. Indeed a selective lesion of this nucleus was the treatment 
of choice for PD, but the success of drug treatment aimed at the DA 
system, combined with an increasing nervousness concerning invasive 
brain techniques meant a decrease in its use that had little to do with its 
efficacy (Tasker et al. 1983).
The development of an animal model of the primary neurochemical 
deficit of PD, the loss of NSP DA has been made using the catecholamine 
neurotoxin 6-OHDA.
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6-OHDA destroys adrenergic neurones in the peripheral nervous system 
producing a selective chemical sympathectomy. Being almost identical to 
the DA molecule (see Figure 6), it is taken up from extracellular space by 
adrenergic axons through their high affinity transport systems. When the 
molecule is metabolised within the cell, it oxidises to compounds that are 
cytotoxic (see Figure 7). In small doses there appears to be no adverse 
effect other than accumulations in the granular vesicles, presumably of 
metabolites that cannot be broken down further or disposed of by the cell. 
However, once the amount of 6-OHDA, or rather its cytotoxic 
metabolites, reach a threshold, the axon and terminals are destroyed. In 
the periphery, the somata will survive and eventually re-innervate their 
target structure. Systemic administration of 6-OHDA has little effect on 
the CNS. As with the DA and DOPA molecules, the 6-OHDA cannot 
easily pass the blood-brain barrier, though 6-OHDOPA can.
Figure 6: DA, NA and 6-OHDA
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Figure 7: Metabolism o f 6-OHDA to its cytotoxic metabolites
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Uretsky and Iversen (1970) compared the effects on NA, DA, 5-HT and 
GABA levels in the rat brain following infusion of 6-OHDA into the 
ventricular CSF. Small doses significantly depleted NA with no 
observable effects on other neurotransmitter levels. A higher dose that 
caused > 80% depletion of brain NA also depleted DA by 66% but had 
no effect on levels of 5-HT or GABA. Assays for the enzymes that 
catalyse the synthesis of DA and ultimately NA, TH and DOPA 
decarboxylase, were also significantly reduced in the striatum and the 
hypothalamus. Peripheral studies had previously shown only destruction 
of NA terminals by 6-OHDA. This study demonstrated that 6-OHDA was 
specifically a catecholamine neurotoxin, having no significant effect on 
the monoamine 5-HT or the amino acid GABA. In contrast to the 
periphery, there was no recovery of NA or DA levels even 142 days after 
administration of 6-OHDA.
Breese and Taylor (1971) administered 6-OHDA intracistemally, 
presumably to the cerebellomedullary cistema as this is where cisternal 
punctures are tapped from. As above, small doses effected only NA, 
larger doses depleting DA as well. The hypotensive agent pargyline
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inhibited the action of MAO-A and MOA-B by binding to the enzyme. 
By administering pargyline systemically 30 mins before the 6-OHDA, the 
efficacy of the depletion of DA was significantly increased. Pargyline is 
thought to have its effect by preventing the deactivation through 
deamination of the 6-OHDA by MAO, but if this is the only method of 
action it is surprising that it has no effect on NA depletion, TH activity in 
the CP was also seen to be significantly reduced indicating a greater 
reduction in DA terminals in the CP. The tricyclic antidepressants block 
uptake of amines through neuronal membrane transport systems. NA and 
5-HT are strongly affected while DA neurones remain unaffected. 
Pretreatment of rats with imipramine or desipramine had no effect on 6- 
OHDA depletion of DA but blocked depletion of NA due to the blockade 
of 6-OHDA uptake.
To appreciate how valuable the selective neurotoxic properties of 6- 
OHDA in combination with desipramine and pargyline is, it should be 
compared with other lesion techniques. Javoy et al. (1976) observed 
similar depletions of CP DA levels following infusion of 2 /ig 6-OHDA 
compared to electrolytic lesion of the SN. The damage to non- 
dopaminergic neurones by 6-OHDA was negligible while 
electrocoagulation caused destruction of all local neurones. Copper 
sulphate causes similarly restricted local cell loss to 6-OHDA but did not 
show a significant reduction in CP DA levels.
A specific lesion of DA-containing NSP neurones allows modelling of 
the primary neurochemical loss in the neurodegenerative disorder, PD. In 
parallel to PD, the loss of DA from the CP has to be almost total before 
any observable symptoms are present. Bilateral 6-OHDA lesions causing 
greater than 90% depletions have been observed to produce motor 
dysfunction; akinesia (an inability to produce motor actions without being
I
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paralysed) and catalepsy (a suspension of voluntary movements associated 
with muscular rigidity). Physiological deficits that may be a direct result 
of the lesion or the motor dysfunction also occur. A bilateral lesion 
causes animals to become aphagic and adipsic and have to be maintained 
on a palatable diet. This might also be attributed to a psychological 
disorder such as loss of motivated behaviour or an inability to integrate 
sensory and motor information, both of which have been described in 
animals having a unilateral lesion.
The gross motor deficits induced by near total depletion of DA from the 
CP can be attenuated by replacing the DA. DOPA administered 
systemically can cross the blood-brain barrier, be hydrolysed to DA and 
raise striatal levels sufficiently to alleviate the gross symptoms. Keefe et 
al. (1989) have also shown a return of motor control in response to 
environment. When dropped into a water bath, a normally akinetic rat 
will for a few seconds produce normal control of musculature. Similarly, 
Apicella et al. (1990) observed co-ordinated control of musculature in 
response to a stressful stimulus in monkeys that had a unilateral 6-OHDA 
lesion and normally demonstrated hypokinesia on the contralateral side.
Chiodo (1988) has shown that a stressful or activating situation increases 
the release of DA from NSP neurones. Presumably the 6-OHDA rats and 
the PD patients have still some intact NSP neurones that respond to the 
situation by increasing DA release, allowing ’normal' control of 
musculature. That the relief from akinesia is only temporary might be due 
to a pharmacological limit of how much DA a neurone can catabolise and 
release over a sustained period, or due to a decrease in stimulation of DA 
release associated with recovery from the initial challenge.
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It has been observed by Snyder et al. (1985) that rats with a partial 
striatal DA depletion while showing no obvious dysfunction demonstrate 
sensorimotor deficits when exposed to a stressor that has a long duration.
It is surprising that the largest component of the basal ganglia can 
tolerate a loss of up to 90% of DA with no apparent loss of function. 
Zigmond et al (1989) have proposed a model of how compensation for 
the loss of NSP DA may occur. A striatal neurone innervated by one NSP 
DA neurone’s terminals will also receive DA released by neighbouring 
NSP neurones. This overlap means that the loss of a few DA neurones in 
a localised area may have little effect while others are still intact. DA is 
removed from the extracellular space by high affinity uptake systems 
located on the presynaptic terminal membrane. This reuptake serves as a 
source for future release or transmitter and also to preclude the DA 
having further effect on the post-synaptic membrane. Thus the loss of one 
axons terminals at a site would allow the DA molecules from outwith the 
site access to the post-synaptic membrane. This is possible as the 
astrocytes that normally enclose synaptic contact, effectively buffering 
from external influence, have been observed by Pickel and Chan (1991) 
to be absent on some striatal neurones innervated by NSP DA. Chiodo 
(1988) observed that there exists a proportion of NSP DA neurones that 
are 'quiescent', they exhibit a baseline firing rate but show no response to 
stimulation. Following 6-OHDA lesion, Zigmond et al. proposed that as 
the lesion increases so the proportion of quiescent DA neurones will 
decrease. Furthermore, there will be an increase in DA released from 
each terminal and an increase in the amount of DA synthesised by each 
neurone. Such an increase in local DA release may be due to reduced 
autoinihibition. Evidence to support such a scheme of recovery come 
from Onn et al. (1986). Bilateral lesions that do not affect gross motor
32
function are known to cause a decrease in the number of DA neurones 
and terminals in the SNPC and CP respectively. Following 
intraventricular administration of 6-OHDA, cell loss was observed in all 
parts of the rat CP but with a mediolateral gradient with most cell-sparing 
in the lateral CP. It would be expected that there would be a similar 
gradient of TH and DOPAC levels across the CP. This was not the case. 
Levels were decreased but less markedly than DA, and there was no 
concentration gradient across the CP. However such lesions do not 
decrease the number of active DA neurones. “40% of SNPC DA 
neurones are quiescent but can be activated by application of the DA 
antagonist haloperidol. Zigmond et al. have also observed a much higher 
extracellular concentration of DA in the CP than would be expected 
following a 6-OHDA lesion.
Investigation of striatal function using bilateral lesion of NSP with 6- 
OHDA is confounded by its gross effect on motor function. The lack of 
response in an animal to a given task might be due to motor dysfunction, 
sensory dysfunction, a sensorimotor integration dysfunction or a 
motivational dysfunction however the animals physical inability to 
respond precludes observation of any other possible accompanying 
dysfunction. An animal with a unilateral lesion however, normally 
displays no behavioural difference to an unoperated animal. It is only 
when the animal is specifically challenged that the pharmacological deficit 
becomes behaviourally manifest.
Carli et al. (1985) demonstrated that such a unilateral lesion produced a 
deficit in making a contralateral response to a contralateral sensory event 
with no sensory, or motor deficits. A rat was required to move its head 
towards or away from a laterally presented light. The rat responded 
correctly to stimuli presented ipsilaterally to the lesion, and when the rat
... ; j
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was required to respond ipsilaterally to a contralaterally presented 
stimulus. This led Carli et al. to propose a role for NSP DA in the 
integration of sensorimotor information.
Brown and Robbins (1991) investigated the role of CP DA in using 
advanced information in a visual spatial discrimination task. Rats were 
required to respond to the left or the right depending on the brightness of 
a bilaterally presented cue. This was presented either in advance of, or 
simultaneously with, an auditory stimulus indicating they should make 
their response. Hence, the task involved a test of simple reaction time (in 
trials with advance presentation of the discriminative cue), or choice 
reaction time where the rat had to make the discrimination and then 
respond. The delay between the onset of the trial and the presentation of 
the auditory stimulus was also a controlled variable. The rats were tested 
before and after a unilateral 6-OHDA lesion of the CP. Rats showed a 
bias in responding post-operatively towards the side of the lesion but 
retained faster responses on the simple than the choice reaction trials. Pre- 
operative trials showed a decrease in reaction time on both tasks with 
increased delay time between trial onset and auditory stimulus 
presentation. The authors suggested this was due to increasing probability 
of stimulus presentation as the period of delay increases. This effect was 
abolished post-operatively on trials requiring responding to the side 
contralateral to the lesion, but remained for ipsilateral response trials.
Brown and Robbins concluded that their study did not support a role for I"Ithe CP in the use of advance information to select particular behavioural 
response, but suggested that the abolition of the delay-dependent decrease |
in reaction time may imply a role for CP DA in preparing the rat to j
respond. ÿ
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Chiodo et al. (1980) were interested in how the dopaminergic neurones 
of the SN respond to environmental stimuli. Using anaesthetized rats, %
first they identified the DA neurones by their electrophysiological ^
characteristics; discharge rate of 1-9 Hz, biphasic action potentials with 
amplitudes of 0.4-1.5 mV and burst firing on discharge. All cells thus 
identified responded to stimuli that are ’activating' to an unanaesthetized 
animal; tail-pinch, air puffs to the face, olfactory stimuli (ammonia) and 
repeated light flash. On the basis of the cells' responses Chiodo et al. 
subdivided the dopaminergic neurones into Type A cells which increased 
their discharge by 2-3 times in response to tail-pinch, and Type B cells 
which decreased relative to baseline firing. Cells responded with a latency 
of 400 msecs with a waveform duration of 0.8-2.0 msec for Type A and 
2.0-2.4 msec for Type B cells. There was also an initial segment, IS- 
spike, associated with Type B that was absent in Type A neurones.
Similar response was found to the air puffs and ammonia. Latency of 
response to the repeated flash light was 1-2 s longer than in response to 
the other three stimuli and had similar effects on both Type A and B 
neurones irrespective of side of presentation, unilateral or bilateral. That 
all neurones respond to all the stimuli argues against the nigrostriatal 
pathway having a role in the identification of a certain stimuli nor in a 
specific behavioural response. In a previous study, Chiodo et al. (1979) 
found that intense pressure to the cervix of conscious female rats, 
inducing the immobilization associated with lordosis, had no effect on 
nigral DA neurones. The same pressure applied elsewhere on the body 
was 'activating' and increased nigral firing. It would appear the nigral 
DA neurones are behaving in manner consistent with the appropriate 
activational response to the environmental stimuli.
Further support for this idea comes from studies on primates. Schultz et 
al. (1983) observed an alteration in DA neurone firing preceding and
during forelimb movement in conscious monkeys. Furthermore, stimuli 
that did not normally elicit a behavioural response from the monkey did 
not activate DA neurones. However, normally activating stimuli caused 
DA neurones to increase firing even if the animal did not produce an 
obvious behavioural response (Ljungberg et al. 1992).
It is apparent that the information reaching the nigral DA neurones has 
already undergone processing that filters for the attribute ’activational'. A 
possible explanation could be that the neocortico-strio-nigral pathway 
could be providing this information. However Grace et al. (1980) 
demonstrated that destruction of the strionigral pathway had no effect on 
stimulation of SNPC neurones by environmental stimuli, although 
Kelland et al. (1989) produced evidence that nigral response to sciatic 
nerve stimulation was increased by a selective D1 receptor agonist (SKF 
38393) administered i.v.. In agreement with Grace et al. transection of 
the strionigral pathway did not block nigral DA neuronal response to 
sciatic nerve stimulation, but did block the enhancement of the D1 
agonist. It would therefore appear that the activation of DA neurones by 
environmental stimuli is mediated by pathways caudal to the DA- 
containing neurones of the midbrain.
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2 Cholinergic control of SNPC and midbrain DA systems 
Non-chollnergic Influences on SNPC neurones
A behavioural study by Kelley and Iversen (1979) analysed the effects of 
SP infused bilaterally into the SN. It was found that stereotyped rearing 
and sniffing were induced after injections of SP (3 pg I nigra) into the SN 
but not after injections into the VTA. Sniffing and rearing were blocked 
by bilateral lesion of the CP with 6-OHDA, which caused an 80% 
depletion of DA from the caudate, but had no significant effect on NAcc 
DA levels.
Neurones of the striatonigral tract innervate SN with SP and the 
chemically similar neurokinin A (substance K). Herrera-Marchitz et al. 
(1986) have shown that nigral infusion of either causes increases in DA 
release in the ipsilateral striatum causing dose-dependent contralateral 
rotation. In a study comparing the actions of agonists and antagonists of 
SP and SK, Reid et al. (1990) have shown that the excitation is probably 
mediated by different receptors as the effects on striatal DA levels of SP 
could be blocked with a specific SP antagonist which had no effect on the 
effect of SK.
The type I striatal neurones innervate the GP and the SNPR with the 
inhibitory amino acid GABA. Amt and Scheel-Kruger (1979) investigated 
the behavioural effects of injecting GABA into the SN. They found that 
contralateral turning following administration of the GABA agonist 
muscimol was unaffected by injection of the DA antagonist haloperidol 
into the SN, CP or NAcc. However, muscimol-induced turning increased 
following a 6-OHDA lesion of the MFB and decreased following 
systemic or intranigral injection of cholinergic agonists. The authors 
conclude that the effects of intranigral muscimol is not mediated by the 
DA systems, but that there is an interaction between GABA, DA and 
ACh in the SN. Intra nigral muscimol has also been shown by Sperber et
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al. (1989) to cause a significant increase in striatal DOPAC, a metabolite 
of DA, but no effect on levels of DA itself. Muscimol also produced I
repetitive head movements and contralateral turning. i
Further evidence for such an interaction was provided by Redgrave et al.
(1980) who demonstrated the involvement of the GABA-ergic nigrotectal 
pathway in the mediation of oral stereotypies produced by systemic 
administration of apomorphine. Experiments in the monkey on saccadic 
eye movements show similar responses by injecting the GABA agonist 
muscimol into SNPR as to injecting the GABA antagonist bicuculline into 
the superior colliculus (Hikosaka and Wurtz 1985). The authors suggest 
that the spontaneous contralateral saccades made by both manipulations 
are analogous to the contralateral turning produced by intra-nigral GABA 
in the rat in releasing the superior colliculus from the SNPR GABA-ergic 
inhibition.
Wirtshafter et al. (1987) demonstrated a serotonergic input to the SNPC 
DA neurones from the dorsal raphe nuclei. The receptors that are affected 
by serotonin have been shown by Fischette et al. (1987) to be 5-HT-IB 
receptors agonists of which have a small inhibitory influence on the firing 
of DA neurones (Sinton and Fallon 1988).
Kelland et al. (1990) have further specified that it is only the slow firing 
DA neurones of the SNPC that are inhibited by serotonergic agonists.
The population of 'fast' DA cells of the SNPC do not respond to 
serotonin or its agonists.
Cholecystokinin C-terminal octapeptide (CCK8) is thought to be co­
localized with the DA neurones of both the SNPC and the VTA, and i.v. 
administration of CCK will stimulate SNPC DA neurones that also 
contain CCK. If CCK is applied microiontophoretically onto such ■%
neurones there is a pronounced increase of firing and especially burst 
firing (Sldrboll et al. 1981).
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The DA neurones of the SN are known to release DA from their i
dendrites within the SN. It is not known whether this is to regulate the I
DA neurones themselves or perhaps neurones afferent to the SN. Groves 
and Linder (1983) discuss evidence for DA receptors on GABA terminals 
in the SN. Groves and Linder attempted to study the nature of dendritic 
synapses in the SN using the 'false' transmitter 5-hydroxydopamine. A 
false transmitter closely resembles in chemical form its 'true' transmitter, 
but only has weak effects on binding with the true transmitter's receptors. 34
As its presence at the receptor complex denies access to the real 
transmitter molecule, the false transmitter effectively acts as antagonist.
In this study, it was being used for its ability to be taken up by the DA 
neurones where its density could be observed in synaptic vesicles using 
EM. The dendrites can be differentiated from axons by their shape, size 
and cytoarchitecture. They discovered that although the dendrites in the 
SNPR only infrequently showed apposition to other dendrites, such |
appositions were observed over relatively long distances in the SNPC. 
twenty-nine dendritic associations were observed in the SNPC with no 
intervening glial processes, as opposed to zero in the SNPR. As discussed 
by Groves and Linder, such synaptic contacts only make up a relatively 
small proportion of the synaptic contacts that occur in SN compared to 
some thalamic nuclei where such appositions are frequent. Thus it appears 
that the DA released from the dendrites of DA neurones in SNPC is 
targeted at the dendrites of other DA neurones. Such an arrangement 
involving in some cases a single dendrite synapsing onto several other 
dendrites could well be a system for maintaining a tonic influence on 
neighbouring neurones. It is unclear what triggers release of DA from the 
dendrites, though it is probable that there is a constant release of DA in 
small quanta. It could be that dendritic release of DA is then accelerated, 
coupled to the propagation of an action potential to cause release at the 4
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release at both sites was blocked by inlra-nigral TTX, suggesting that DA 'A
release from the terminals in the CP and from dendrites in the SN is 
dependent on the firing of action potentials of nigral neurones. However,
because the measurement of DA release in the SN was near the lowest ‘ C
■ I Ilevel of detection by the technique employed, a DA uptake blocker
- inomifensine was used increasing DA output seven fold in the SN.
Although this is still evidence that DA release in the SN is tied to the 
propagation of action potentials by SNPC neurones, replication with a 
more sensitive technique precluding the need to use an uptake blocker 
would be preferable. The tying of dendritic DA release to the action 
potential is suggestive, but not conclusive evidence, that DA release in 
the SN is concurrent with DA release at the terminals in the CP. The 
release of DA from SN dendrites may still be an indirect result caused by 
striatal DA release influencing striatonigral efferents which in turn cause 
the dendritic release of DA.
Chiodo (1988) discusses evidence that the self-inhibition of SNPC 
neurones is mediated by D2 autoreceptors. These are present on the 
somatodendritic region of the neurones and are much more sensitive than 
DA receptors on type I CP neurones (Skirboll 1979). In vitro studies have 
shown that they produce K“^  currents using a mechanism that is 
dependent on the presence of the nucleotide guanine. Such autoreceptors 
are not present on the DA neurones of the VTA. It is clear that the DA 
neurones of the SNPC have many pharmacological influences on their 
post-synaptic membranes, both on their somata and dendrites in the PC 
and on their dendrites in the PR. Kelland et al. (1988) have shown that 
the inhibition of NSP DA neurones by the D2 agonist quinpirole was 
positively correlated with the baseline activity of the neurones. The ’fast'
DA neurones were inhibited only by much higher doses of the agonist 
than the 'slow' population of neurones. Kelland et al. suggest this is due
' .a . — - •— — '  ■' ■ ■J
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to there being fewer somatodendritic autoreceptors on the 'fast' NSP DA 
neurones.
Most of the influences on SNPC DA neurones appeared for a long time 
to be inhibitory, GABA from the dorsal and ventral striatum mediated by 
GABA^ receptors, serotonin from the dorsal raphe nuclei mediated by 5- 
HT-IB receptors and DA from the dendritic processes of the DA 
neurones themselves. Characterisation of excitatory influences on the DA 
neurones is on the increase. This probably reflects the advances in 
technology for the studying of peptides that proved harder to localize than 
the predominantly inhibitory catecholamines. SP and substance K 
(neurokinin A) all thought to be projected from the CP join ACh and 
possibly SP from the PPTg as excitatory influences on the SNPC DA 
neurones. lontophoretic administration of glutamate has been reported to 
increase 'burst firing' in NSP DA neurones (Grace and Bunney 1984). 
This effect is blocked by the NMD A antagonist (+/-)-4-(3-
phosphonopropyl)-2-piperazine carboxylic acid (Overton and Clark 
1992). This is suggestive of an excitatory amino acid influence on NSP 
DA neurones mediated by NMDA glutamate receptors. Scamati et al. 
(1986) have produced evidence that SNPC neurones are influenced by 
glutamate from neurones on the PPTg.
There is now considerable evidence from a number of disciplines to 
suggest an excitatory cholinergic influence on the DA-containing 
neurones of the SNPC. The rest of this chapter will describe
acetylcholine, its action as a neurotransmitter, and the evidence for a 
functional cholinergic-dopaminergic interaction in the SN.
Acetylcholine as a neurotransmitter
Proteins vital for the synthesis of the neurotransmitter ACh, the amine
base choline and the enzyme which catalyses the synthesis of ACh
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(Cheney et al. 1975), ChAT as well as a certain amount of the 
neurotransmitter itself (Chubb et al. 1980) have been shown to be present 
in SN. ChAT is synthesized in the ribosomes of neuronal soma and 
transported to axonal terminals by axoplasmic flow. It is known to be 
located mostly in the axoplasm with some association with the membranes 
of synaptic vesicles. Choline exists in the extracellular fluid and can be 
transported into cells by a relatively low-affinity transport mechanism by 
non-cholinergic cells for its role in normal cell metabolism. In cholinergic 
axon terminals there is a high-affinity carrier-facilitated transport 
mechanism which allows cholinergic neurones to maintain a constant 
supply of choline for the synthesis of ACh. It is known that glucose, 
oxygen and sodium ions are vital for ACh synthesis. ACh is stored in 
vesicles (40-50 nm, containing 2000-40000 molecules of ACh) in the 
cholinergic terminals which migrate to the presynaptic cell wall, merge 
with it and rupture spilling its contents into the synaptic cleft. Even when 
neurones are not firing, ACh is constantly being released in small quanta. 
This process is massively accelerated when neurones fire and nerve 
impulses depolarize membranes. In the region of 250-4(X) vesicles will 
discharge releasing over 4 million molecules of ACh from one 
presynaptic membrane. The amount of ACh released will be limited if 
there is an insufficient concentration of Ca^"^ in the extracellular fluid. It 
is thought they link the arrival of the nerve impulse to the release of the 
neurotransmitter. In contrast, magnesium ions will inhibit the release of 
ACh if in too great a concentration. ACh release at a terminal site can 
thus be seen, to some extent, to be a function of the concentration of Ca 
and Mg in the synaptic cleft. Massey and James (1978) have 
demonstrated the presence of both a sodium-dependent high affinity 
choline uptake mechanism and a calcium-dependent release mechanism in 
the SN.
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Cholinergic neurotransnûssion is mediated by two main subclasses of 
receptor named after their classic agonists. Binding at nicotinic and 
muscarinic receptors produces different effects on the neuronal membrane 
(Figure 8). It is thought that ACh acts in its same preferred conformation 
at both receptor types, but different parts of the molecule form the link 
with each receptor complex. By comparing the structure of ACh itself 
with the structure of selective agonists for the two sub-types (Figure 9) it 
has been inferred that for nicotinic receptors it is the cationic head and the 
carbonyl oxygen atom, while for the muscarinic it is the cationic head, 
the ether oxygen and the terminal methyl group which are vital for the 
link. Muscarine, the classic muscarinic agonist, does not have a carbonyl 
group and so has little effect on nicotinic receptors, while the ether 
oxygen atom of nicotine is blocked from interacting with muscarinic 
receptors by the position of the alpha-methyl group of the molecule.
Figure 8: Fffects o f ACh mediated by nicotinic and muscarinic receptors 
on neuronal membranes
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Figure 9: Chemical composition o f ACh and nicotinic and muscarinic
agonists
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The binding of ACh with a cholinoceptive receptor complex will induce 
changes in the permeability of the membrane to Na'*'* K"*" and Ca^“^ . 
The Na"^ which is in a higher concentration outwith the cell flows 
inwards as does to a lesser extent Ca^"^, while which has a higher 
concentration inside the cell, flows outwards.
The neuropharmacological effects of ACh on the post-synaptic 
membrane cannot be classified simply as excitatory or inhibitory (Brown 
1986). Indeed ACh can have an excitatory or inhibitory effect, or an 
effect more akin to potentiation. Potentiation is where the membrane 
shows a reaction to the binding of one ligand followed by another perhaps 
different ligand which is different to that of the sum of its reactions to the 
two ligands separately. Kemp (1977) has suggested that ACh acts as a 
'fast' neurotransmitter (referring to its duration of binding with the 
receptor complex) when acting at nicotinic receptors, and as a 'slow* 
neurotransmitter when acting on muscarinic cholinergic receptors. When 
acting as a fast transmitter its effect appears to be consistently excitatory
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on the post-synaptic membrane, but when acting as a slow transmitter it 
can be excitatory, inhibitory or potentiating.
After binding with the receptor complex ACh is deactivated by 
hydrolysis to its constituent choline and coenzyme A. There is a family of 
enzymes which catalyse the deactivation of choline esters. The one that 
deactivates ACh more potently than the rest is acetylcholinesterase 
(AChE). It is estimated (Bowman & Rand 1980, p. 10.33) that each 
active site of the enzyme can hydrolyse 4 x 10^ ACh molecules per 
minute. Anticholinesterases such as neostigmine and physostigmine - also 
known as eserine - (see Figure 10), block the de-activation of ACh by 
AChE and hence act as cholinergic agonists.
Figure 10: Chemical composition o f anticholinesterases
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ACh and SNPC neurones 
Muscarinic receptors and SNPC neurones 
Cross and Waddington (1980) made unilateral lesions of the NSP using 
the catecholamine neurotoxin 6-OHDA. The nigrae were removed to 
compare in vitro the specific binding of a tritiated muscarinic receptor 
ligand, [^H] quinuclidinyl benzylate. A 30% decrease in specific binding 
of (^FQQNB in the homogenate of the nigra ipsilateral to the lesion 
compared to the control side was observed. This could be explained by 
either a decrease in the number of muscarinic rec^tors in response to the 
lesion, or a change in their affinity state. The latter would suggest that
I
I
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muscarinic receptors were present in the SN but not localized to the DA 
neurones of the NSP and possessing a high degree of plasticity. This was 
resolved using a technique for analysing protein-binding data called 
Scatchard analysis which relates the concentration of the protein to the 
concentration of the protein bound to the receptor sites. The shape of the 
plot in response to various concentrations of the drug reveals the affinity 
state of the receptor, assuming homogeneity of receptor type. Such 
analysis suggested that the decrease in specific binding of [^H]QNB was 
due to a decrease in the number of muscarinic receptors with minimal 
alteration to their affinity state and hence localisation of muscarinic 
receptors to DA NSP neurones.
Of the five types of muscarinic receptor that have been described on the 
basis of molecular structure (ml-m5), only the m5 receptor sub-type was 
found to be present on medial SNPC neurones (Weiner et al. 1990). The 
m5 receptor is thought to conform to the M l recqitor described by 
pharmacological studies (described as M l-M3, Buckley et al. 1989). Ml 
receptors stimulate phosphoinositide hydrolysis and inhibit cAMP 
production. The hydrolysis of triphosphoinositol (inositol 1,4,5- 
triphosphate) releases calcium from intracellular stores. M2 receptors are 
coupled to adenylate cyclase which increases cAMP levels. M2 receptors 
are also linked to K’*’ channels. M3 receptors are coupled to arachidonic 
acid metabolism (Mei et al. 1987).
Lacey et al. (1990) identified eîectrophysiologically 114 DA neurones in 
the mesencephalon; 30 in the SNPC, 84 in the VTA. Muscarine (3-100 
uM) increased the firing rate of active neurones by up to 4(X)%, and 
caused firing of quiescent neurones (neurones that were not firing). There 
appeared to be no difference in response between the SNPC and VTA DA 
neurones. The effects of muscarine on the DA neurones was blocked by 
the Ml muscarinic antagonist pirenzepine.
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Thus it would appear that cholinergic stimulation of the SNPC and VTA 
DA neurones when mediated by muscarinic receptors is through the m5 / 
Ml receptor sub-type as described by molecular / pharmacological 
nomenclature, respectively.
Nicotinic receptors and SNPC neurones 
Autoradiographic evidence suggesting the localisation of nicotinic 
receptors to DA NSP neurones was provided by Clarke and Pert (1985) 
and Clarke et al. (1985). As in the previous study a unilateral lesion of 
the NSP with 6-OHDA was followed by labelling with a tritiated 
compound, in this case [^H] nicotine. Unlike the assay procedure used in 
the previous study where the nigral tissue was homogenized and all cell 
differentiation lost, autoradiography is crucially dependent on the 
preservation of slices of the brain with the tritiated compound in situ, 
bound to the target receptor. The slice is incubated in a light-proof 
container against tritium-sensitive film and by localising the radiation, 
detection of where the tritiated compound is bound is possible, thus 
revealing where the nicotinic receptors are. They then used computer 
aided densitometry to asses how intense the radiation, and hence the 
binding, was. [^H] nicotinic binding in the anterior SN was found to be 
"45 % of the control SN, suggesting a localisation of nicotinic receptors to 
the DA NSP neurones. In the same study, Clarke and Pert (1985) showed 
localisation of nicotinic receptors to mesolimbic neurones, that is, those 
neurones projecting from the VTA to the NAcc. These neurones increase 
their firing rate following microinjection of the cholinergic agonist 
nicotine (Grenhoff et al. 1986).
In an attempt to characterise the effects of cholinergic binding on SNPC 
DA neurones Lichtensteiger et al. (1982) administered nicotine to the SN 
using microiontophoresis. This electrophysiological technique uses a glass
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micropipette (tip diameter "2-6 u) attached to a recording electrode. The 
pipette is introduced into the brain and by studying the firing activity 
from the recording electrode it is possible to localise the tip onto or even 
pierce a target neurone. The positively ionized nicotine, held in the 
micropipette by a small negative current, can then be released by the 
passage of a small positive charge ("10 nA) down the pipette which repels 
the ionized nicotine. The only way of controlling the amount of fluid 
released is by the length of time the current is reversed for.
It was found that administration of nicotine or ACh accelerated the 
firing of the DA neurones. Furthermore, administration of the specific 
nicotinic antagonist dihydro-beta-erythroidine blocked the excitatory 
effect of nicotine and ACh, whereas the specific muscarinic antagonist 
atropine caused little or no blocking of the excitatory effect. This suggests 
that the effect of cholinergic binding on SNPC DA neurones was 
excitatory in nature and mediated by nicotinic but not muscarinic 
receptors. Having established a profile of nigrostriatal firing in response 
to nicotinic stimulation of SN, Lichtensteiger et al. then measured DA 
turnover rate in the striatum in response to electrical stimulation of the 
NSP at the same average frequency as produced by nicotine (“10 Hz). 
They found a similar increase in DA turnover as to nicotine but if they 
produced the same average frequency by using a higher frequency only 
intermittently, the change in DA turnover dropped to an insignificant 
level. This suggests the DA release was to some extent dependent on a 
pattern of stimulation caused by the nicotine rather than just responding 
non-specifically to a certain level of stimulation.
The pharmacological specificity of the cholinergic stimulation of SN 
neurones suggested by Lichtensteiger et al. is however questioned by 
other studies including that of Massey and James (1978). They found that 
infusion of ACh excited 105 and inhibited 20 out of 190 neurones tested;
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nicotine excited 40 and inhibited 2 out of 70 tested; and the muscarinic 
agonist carbachol excited 15 and inhibited 1 out of 19 neurones tested. 
Pre-treatment with the muscarinic antagonist atropine blocked excitation 
by ACh in 2 out of 3 tested and blocked both of the nicotinic excitations 
that were tested. This admittedly small sample of results would tend to 
suggest that cholinergic binding to SNPC DA neurones can produce 
excitation when mediated by nicotinic and muscarinic receptors.
AChE and SNPC neurones
Shute and Lewis (1967) demonstrated a 'ventral tegmental pathway' 
arising from neurones in the SNPC and the VTA accumulated AChE 
caudal to the site of a radiofrequency lesion. That the accumulation was 
caudal, rather than rostral, to the lesion suggested that the neurones were 
ascending. Shute and Lewis mapped their innervation of, among others, 
limbic and basal ganglia sites including the CP.
Butcher and Talbot (1978) review the evidence accumulated from their 
studies that demonstrate that 80-90% of SNPC neurones contain AChE. 
Given that a similar percentage of SNPC neurones contained DA and 
demonstrated a similar histological profile. Butcher and Talbot concluded 
that most if not all SNPC DA neurones contained AChE and suggested a 
cholinergic-dopaminergic interaction at the level of the SNPC.
The presence of AChE in SN was demonstrated by Lehmann and 
Fibiger (1978) who showed it was AChE present in SNPC neurones and 
not one of the other enzymes of that family. This they did using three 
pharmacological criteria; substrate selectivity, pharmacokinetics and 
selective inhibition. Any enzyme will show maximal activity in the 
presence of a specific substrate. Therefore the identity of any enzyme 
may be inferred by characterising the target enzyme's activity in the 
presence of suitable substrates. Pharmacokinetics refers to the effect on
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the cholinesterase of the environment it is in. More specifically, by 
studying the concentrations of putatively different cholinesterases (such as 
acetyl- and butyrylcholinesterases) in a particular neurochemical 
environment, they may be differentiated by their rates of chemical 
transformation in response to that medium. Selective inhibition is where 
the cholinesterase is displaced at a given site by a similar but inactive 
protein and hence the normal pharmacological action of the cholinesterase 
is blocked. As each cholinesterase has its own selective inhibitor, the 
identity of the target cholinesterase can be determined by comparing the 
action of several selective inhibitors of candidate cholinesterases. Having 
made a unilateral lesion of the NSP using 6-OHDA, the SN was removed 
for enzyme bioassays (the estimation of the amount of a given enzyme in 
a tissue extract) using the contralateral SN as control. The bioassay 
showed no difference in ChAT levels in the two nigrae suggesting the 
ChAT present in SN was not localized to the NSP DA neurones. 
However, the cholinesterase present was found to have decreased by 
"43% compared to control. They then used the three criteria explained 
above to identify the cholinesterase. True AChE hydrolyses ACh faster 
than it hydrolyses acetyl-beta-methylcholine, which it in turn hydrolyses 
faster than butyrylcholine. The main pseudocholinesterase, 
butyrylcholinesterase, hydrolyses these three substrates with different 
velocities (BCh >  ACh > A-beta-Ch). It was found that the 
cholinesterase from SN had a hydrolysing profile which conformed to that 
of true AChE. Pharmacokinetic velocity refers to the speed of the 
chemical transformation of a drug in the presence of a substrate. The 
velocity profile of nigral cholinesterase corresponded more closely to true 
AChE than that for BChE which showed less inhibition by higher 
concentrations of ACh. Finally, the responses of nigral ChE, true AChE 
and BChE to two AChE and one BChE selective inhibitors were
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compared. The BChE inhibitor only affected the nigral ChE at 
concentrations that similarly affected true AChE. Both the nigral ChE and 
the true AChE gave a similar dose response curve to the AChE inhibitors 
while the curve for BChE was very different. Lehmann and Fibiger 
therefore provided strong evidence for the localisation of a cholinesterase 
to NSP DA neurones, and that the cholinesterase was AChE.
Henderson (1981) further characterised the distribution of AChE in the 
SN using a combination of EM, HRP labelling and AChE histochemistry. 
AChE was present in two types of cell in the SNPC; the majority of cells 
had a large cell body and were labelled with HRP injected into the CP; 
the smaller cell type were not labelled with HRP. AChE was observed not 
only in the cell bodies but also in the neuropil suggesting that AChE may 
be localised to the dendrites as well as the cell bodies of SNPC neurones.
Does AChE have other functions in SN ?
Although AChE will be present wherever ACh is present, it is also 
present in some areas in quantities far greater than would be needed to 
hydrolyse the ACh present - including the SN - and is therefore now seen 
as a bad marker for cholinergic activity. Its presence is necessary but not 
sufficient to indicate cholinergic transmission in a certain area. The 
synthesizing enzyme for ACh, ChAT is thought to be a much better 
marker. Levels of ChAT measured in structures correlate well with sites 
known to have cholinergic neurones or terminals.
That AChE may have functions in the CNS other than hydrolysing ACh 
is suggested by its topographical mismatch with the neurotransmitter. Its 
localization in many adrenergic tissues supports an hypothesis proposed 
by Bum & Rand (1959) that ACh has a role in facilitating noradrenaline 
release. From peripheral studies (Bowman and Rand 1980) of the superior 
cervical ganglion, the latency of firing of the neurones and knowledge of
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the pharmacological conditions suggest that diffusion of ACh from the 
site alone could account for the cessation of cholinergic influence on the 
post-synaptic site. As it seems the AChE present is unnecessary for its 
classical role in the hydrolysis of normal levels of endogenous ACh, 
additional explanations might be sought for its presence at the post- 
synaptic site. Although this is at a peripheral site, similar instances may 
well be present in the CNS.
Greenfield has proposed many functions for AChE in the SN, in fact, 
every function other than the hydrolysis of ACh. There is a large amount 
of AChE in the cerebrospinal fluid. Greenfield and Smith (1979) have 
shown that the increase in CSF AChE following stimulation of the CP is 
blocked by a lesion of the ipsilateral SN. They conclude that the SN may 
be the source of CSF AChE. In an attempt to delineate further the AChE 
release, potassium was injected into SN. This caused an increase in nigral 
AChE, a decrease in ipsilateral striatal AChE, and had the reverse effects 
on DA levels at these two sites. If, as is thought, the AChE is released by 
dendrites of SN DA neurones, this means the AChE and DA are acting 
differently in response to the same signal. This suggests that AChE 
release in the SN is not a non-specific release, nor is it released 
sympathetically with DA. The release of AChE in SN might then have 
specific physiological functions. However the introduction of exogenous 
potassium ions can have varying effects on the neuronal membrane 
dependent on its concentration. Relatively small amounts will depolarize 
the membrane and increasing the probability of firing. However if a large 
amount is added depolarization will occur unevenly over the membrane 
causing repeated action potentials. Thus how physiologically relevant 
Greenfield's study of the effects of exogenous potassium on SN is 
questionable.
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AChE has been demonstrated by Greenfield et al. (1988) to have a 
depressive effect on nigrostriatal neurones. This would be predicted if it 
was deactivating an excitatory cholinergic input to SN. However, this 
effect has been shown by Greenfield et al. (1988) even in the presence of 
soman, an irreversible inhibitor of the enzymatic activity of AChE. There 
exist two types of cholinesterase inhibitors which may be differentiated by 
their chemical composition and the stability of the complex they form 
with the enzyme. Reversible anticholinesterases like physostigmine and 
neostigmine have a chemical composition similar to ACh and form 
relatively short-lasting complexes with AChE. Irreversible 
anticholinesterases like soman form a complex with the AChE that is 
stable and bear no similarity to the ACh molecule. The enzyme is 
deactivated by the dissociation of the phosphoryl group from AChE by 
hydrolysis. This process may take months to complete, hence the 
appearance of the deactivation of the enzyme being irreversible. Such 
studies as Greenfield's are unfortunately confounded to a certain extent by 
the ability of anticholinesterases to stimulate release of ACh itself from 
the pre-synaptic terminal. This action is potentially quite independent of 
its action as an enzyme and hence could provide an alternative 
explanation for the modification of nigral activity by its infusion into the 
SN.
Taylor and Greenfield (1989) suggested that the release of AChE is not 
obviously related to nigral DA neurone firing, but may reflect instead the 
level of excitation of inputs to the SN, especially that from the CP. 
Unfortunately, other than AChE release following stimulation of the CP 
there is little evidence to support it, nor is it clear what predictions would 
follow were it true. If the level of AChE was acting as a barometer of 
input to the nigra, it might be predicted that exogenous AChE might 
increase behaviour associated with the SN. Potassium-evoked release of
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AChE caused no visible change in behaviour (Taylor et al. 1990). 
Greenfield concludes that AChE release is instead a measure of 
sensorimotor events. It will be interesting to see what evidence is 
produced to support such an hypothesis, perhaps using a paradigm such as 
that of Carli et al. (1985) that seeks to dissociate motor, sensory and 
sensorimotor functions.
AChE has also been shown in vitro to hydrolyse the peptide 
neurotransmitter SP. SP is co-Iocalized with ACh in several brain sites 
including the ascending reticular system (Vincent et al. 1983). It also 
makes up part of the projection to SN from the CP. Administration of 
nicotine to nigral slices inhibits release of SP (Torrens et al. 1981). SP 
has little effect directly on SNPC DA neurones (Chiodo et al. 1987) and 
although there is a relatively high concentration in the SN there appears to 
be few binding sites (Quirion et al. 1983). This leaves us with a 
surprisingly large amount of a neurotransmitter with nowhere to go, and a 
surprisingly large amount of an enzyme that could de-activate said 
neurotransmitter in the same area of the brain. This does not lead us to 
any functional explanation for their presence in the SN, but leaves the 
possibility that the two may be connected.
The pedunculopontme tegmental nucleus
The PPTg is a relatively small nucleus in the pontomesencephalic 
tegmentum. It lies rostral to the peribrachial nuclei, ventral to the lateral 
lemniscus, dorsal to the pontine reticular formation and lateral to the 
medial portion of the brachium conjunctivum at the level of the trochlear 
nucleus. At its most rostral, ectopic neurones are seen to abut on the SN. 
The rostro-caudal length of the group is 500-8(X) urn and the mediolateral 
diameter is 400-500 urn at the rostro-caudal middle of the cell group.
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The PPTg is thought to be involved in the control of motor activity. It 
has been shown by Jackson and Crossman (1983) to be a projection area 
of the motor cortex areas 4 and 6. Locomotion-like movements can be 
elicited by electrical or chemical stimulation of the mesencephalic 
locomotor region, of which the PPTg is thought by some to be a part 
(Garcia-Rill et al. 1985), but a recent study has demonstrated that 
locomotion is associated with activity in the cuneiform nucleus rather than 
the PPTg (Shojania et al. 1992). PPTg neurones are also reported to be 
rhythmically active when an animal is moving (Garcia-Rill et al. 1983). 
Electrophysiological studies have shown that electrical stimulation of the 
PPTg evokes an excitatory response in SNPC and SNPR (Clarke et al. 
1987, Scamati et al. 1984).
In 1963 Kaebler demonstrated a resting tremor by making electrolytic 
lesions of the cat tegmentum. The animals also showed hyperphagia and a 
presumably associated increase in weight. Unfortunately, there was great 
variance in the extent of the lesions produced, and as such Kaebler could 
not delineate destruction of which tegmental structures were necessary or 
sufficient for the production of tremor. Kaebler suggested that the lesions 
were having their effect by destroying nigro-reticular pathways.
Clinical studies have noted abnormalities in the PPTg of patients who 
suffered from PD. Zweig (1987) reported a significant loss of neurones 
>20 urn from the PPTg PC in three out of four PD patients and three out 
of four patients suffering from PD and Alzheimer’s disease (AD). There 
were also Lewy bodies present in the PPTg PC; their presence in the 
SNPC is a well-documented feature of the Parkinsonian brain. Jellinger 
(1988) compared large cell loss from the PPTg PC in PD, AD and 
progressive supranuclear palsy (PSP) with that of control brains. PD 
brains (n=14) had roughly half the number and density of large neurones 
compared to controls, AD patients (n—17) lost 29% of large neurones
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and PSP brains had lost 60% (n=2) of PPTg PC large neurones. These 
large neurones of the PPTg PC were presumed to be cholinergic. These 
data suggest that AD, although associated with loss of cholinergic 
innervation of the cerebral cortex from neurones in the nucleus basalis of 
Meynert, does not feature a severe loss of PPTg ACh neurones. However 
these two studies do suggest a PPTg cell loss in PD and, though with a 
small sample size, PSP. The cell loss from the PPTg in these two clinical 
conditions which feature motor dysfunction may not be causative of these 
conditions, but could cascade from the loss of neurones afferent to this 
area that are crucial to the clinical features of these conditions.
Karson et al, (1991) have produced evidence from a small subject 
sample suggesting that the number of cholinergic cells in the PPTg is 
greater in schizophrenic than non-schizophrenic human brains at post­
mortem. Just as PD is classically associated with a loss of nigrostriatal 
DA, schizophrenia is associated with an over-activity in the DA system, 
although whether this is tied to DA release or receptor changes is unclear. 
However, if there is an increased number of cholinergic PPTg neurones, 
it is an attractive proposition that the positive symptoms of schizophrenia 
might be tied to their over-stimulation of the midbrain DA systems.
The PPTg and the basal ganglia
Anatomy
Probably the earliest demonstrations of a connection between the PPTg 
and the basal ganglia showed a labelling of the SNPC following the 
injection of amino acids labelled with tritium into the PPTg of the rat 
(Saper & Loewy 1982), and cat (Moon Edley & Graybiel 1983). This 
was followed by Jackson & Crossman (1983) using anterograde and 
retrograde transport of horseradish peroxidase (HRP, an enzyme 
transported in neurones axoplasmically).
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The basal ganglia has historically been viewed as a collection of 
primarily inhibitory 'loop' systems, with the various nuclei seen as 
'restraining' the firing of the nucleus/nuclei it projects to. The SNPC has ^
inhibitory inputs from the CP, NAcc and also the medial raphe nuclei. |
McGeer and McGeer (1984) proposed that the SN received a probably 
excitatory cholinergic innervation from the PPTg. Following injection of 
the potent excitotoxin kainate into the PPTg PC, cell death and a loss of 
ChAT activity in the pars compacta of the SN was observed. McGeer and 
McGeer proposed that it may be overexcitation of the PPTg projection to 
the SN that induces necrosis of cholinoceptive DA neurones in SN in PD.
1
Sugimoto & Hattori (1984) define the pars compacta area of the PPTg as 
the area populated by large (2(XX)-6000 um^) neurones. To map the |
efferent projections areas of the PPTg, leucine labelled with a radioactive 
form of hydrogen, tritium, was injected into the PPTg PC. Sections were 
then cut and treated with photosensitive emulsion. Where the silver grains 
of the emulsion are observed using EM will show where the efferent 
projections of the PPTg PC have transported the tritiated leucine. Silver 
grains were observed in the VTA, SNPC, zona incerta and the lateral 
hypothalamic area (LHA), showing that fibre bundles project to or 
through these areas. Tritiated choline injections to the thalamus and STN 
produced retrograde labelling of the PPTg PC but no such labelling was 
observed following similar injections to SN. Interestingly, monosynaptic 
projections were observed from the PPTg PC to thalamostriatal neurones.
In 1986, Scamati et al. used microiontophoresis to attempt to 
characterise the nature of the putative excitatory projection from the PPTg 
to SNPC. Using electrophysiological techniques, 120 nigral neurones 
were recognized as having PC DA neurone characteristics; slow firing 
rate, triphasic shape and long duration of action potentials. Short latency 
orthodromic excitation was observed in 30 of these cells following
..W
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electrical stimulation of the peribrachial area. ACh infused into the 
peribrachial area induced activation in 4 cells all of which were 
antagonized by atropine (50-200 nA) suggesting the cholinergic 
stimulation was perhaps mediated by muscarinic receptors. Glutamate (5- 
10 nA), however, excited all 30 neurones, and this excitation was 
antagonized by glutamate antagonists glutamic acid diethylester (GDEE) 
and D-alpha-aminoadipic acid (DAA). Atropine did not antagonise the 
excitatory effects of glutamate, nor did the glutamate antagonists 
antagonise the excitatory effects of ACh. Scamati et al. concluded that 
although there was a cholinergic population in the PPTg, reports of its 
projection to the SNPC could be explained as fibres projecting through 
the SNPC en route to other structures.
Woolf and Butcher (1986) provided evidence for a cholinergic projection 
from PPTg to SNPC using ChAT immunohistochemistry 
(immunohistochemistry: the study of antibodies, antigens and their 
interactions when administered to histological sections), fluorescent tracer 
histology (whereby antibodies tagged with a fluorescent dye enable 
cellular components to be resolved using a fluorescent microscope), and 
AChE pharmohistochemistry. Fluorescent tracers injected into the SN 
produced labelled in the PPTg and LDTN. Neurones containing AChE 
were observed to innervate the SN from the PPTg and LDTN. However, 
although this suggests there is a projection from the pontine to the SN, 
ChAT immunohistochemistry suggested it was not cholinergic in nature.
In 1987 Scamati et al. further characterized the PPTg-SN projection 
describing two types of neurones projecting to the SN, one having a 
relatively low firing rate of 0.5-8 spikes/s and a triphasic impulse with 
duration 3-4 ms, the second having a firing rate of 15-20 spikes/s with a 
biphasic impulse lasting less than 3 ms. There was no attempt to identify 
the neurotransmitter mediating the excitatory influence of both types of
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PPTg neurones on SN neurones. In an EM and Golgi study Scamati et ai. 
(1988) found degenerated terminals in the SN following electrolytic lesion 
of the PPTg. These were seen to make contact on dendritic processes of 
dendritic shafts. Post-synaptic high electron density was observed and was 
thought to represent a post-synaptic thickening. The PPTg contained 4 
types of neurone based on morphology. Both large (20-40 ^m), 
multiangular and medium angular shaped neurones appeared to have 
axons projecting outside the PPTg.
These reports show a projection from the PPTg to the SNPC, but 
equivocal evidence for it being cholinergic in nature. This view has been 
proposed probably most strongly by Wainer and his colleagues who 
believed that those few neurones that did project from the PPTg to SNPC 
were firstly non-cholinergic in nature, and secondly ectopic neurones of 
the midbrain extrapyramidal area (MEA, see Figure 11), (Lee et al, 
1988).
Lee et al. used ChAT immunohistochemistry and retrograde tracing to 
map the projections to and from the MEA and PPTg. The MEA is 
defined as the non-cholinergic neurones medial to the cholinergic 
neurones of the PPTg. As is clear from the diagram, the thalamus is the 
major target of PPTg neurones, while the MEA appears to project to most 
of the basal ganglia, including the SNPC. The only significant retrograde 
labelling of PPTg following injections to SN were those where the 
injection had been shown to spread beyond SN.
However, using a similar approach to Wainer and his colleagues 
Beninato & Spencer (1987) found very different results, using 
simultaneous retrograde labelling by HRP and ChAT 
immunohistochemistry. HRP was injected into SN and subsequently 
localized on sections of the rat brain, followed by immunocytochemical 
localisation of ChAT. HRP labelling was found in the PPTg in proportion
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Figure 11: Projection sites o f the PPTg and mdbrain extrapyramidal area 
(redrawn from Lee et al. 1988).
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to the size of the injection in SN. ChAT-immunoreactive neurones were 
found to exist in the PPTg and the LDTN. Double-labelled neurones, i.e. 
by HRP retrograde transport from SN and ChAT immunoreactivity, were 
found throughout the ipsilateral PPTg.
Although this suggests a cholinergic projection to SN, it is unclear 
whether the projection is to SNPC, SNPR, or both. Neuroanatomical and 
electrophysiological evidence for a cholinergic projection from PPTg to 
SNPC was provided by Clarke et al. (1987). First a double-labelling 
procedure was used to confirm that cholinergic neurones of the PPTg 
projected to SN. Then in the electrophysiological part of the study kainate 
was injected into the peribrachial area causing dose-dependent stimulation 
of SNPC neurones. The latency of the excitation of the SNPC neurones 
was thought to be too quick to have been caused by diffusion of kainate to 
SNPC to effect the neurones directly. It was also found that intraveneous 
administration of the nicotinic cholinergic antagonist mecamylamine 
blocked the stimulation at the same dose as blocks direct stimulation of 
SNPC neurones with nicotine. This suggests that there are nicotinic 
receptors on the SNPC DA neurones mediating cholinergic stimulation 
from the PPTg.
Tokuno et al. (1988) provided electron microscopical evidence that 
SNPC nigrostriatal neurones receive monosynaptic projection from the 
PPTg. An electrolytic lesion of the cat PPTg was made and HRP injected 
into the CP. EM revealed that degenerating axon terminals in SNPC 
made asymmetric contact with dendrites of neurones labelled with HRP. 
As in a control condition with no lesion to PPTg there were no 
degenerating axon terminals in SNPC, it is most probable that the 
terminals were from neurones in the PPTg, synapsing directly onto 
dopaminergic dendrites of the SNPC.
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As a direct answer to the findings of Wainer and his colleagues, Gould, 
Woolf and Butcher (1989) used the same techniques but with a more 
complicated protocol for enhanced demonstration of ChAT-like 
immunoreactivity. Following infusions of the fluorescent tracers True 
Blue, propidium iodide or fluorogold to rat SNPC, neurones showing 
retrograde tracing from SNPC and ChAT-like immunoreactivity in the 
PPTg and LDTN were observed. Specifically, the cells were all larger 
than 15 um and found in the ipsilateral PPTg. This agrees with the 
description of PPTg-fugal neurones by Scamati et al. (1988). Specific 
infusions of tracer into SNPC revealed 2-3 times as many neurones 
labelled in PPTg and LDTN than infusions into SNPR. Gould et al. also 
observed what they describe as 'bouton-like protuberances' in the SN 
following anterograde tracing with a similar distribution observed with 
ChAT immunoreactivity in SN. Woolf et al. (1990) similarly showed 
cholinergic projection from PPTg-LDTN to SNPC in the cat.
Martinez-Murillo et al. (1989) also used ChAT immunoreactivity to 
show asymmetric synaptic specialisations between cholinergic terminals 
and unlabelled dendrites in areas of the SNPC where there were no 
ChAT-positive neurones. The authors suggested that the surrounding glial 
cells were effectively isolating the points of synaptic contact between the 
cholinergic neurones and the SNPC DA neurones and that this implied a 
functional relationship between them.
Probably the clearest evidence for a cholinergic innervation of SNPC 
DA neurones is a double immunocytochemical study by Bolam et al. 
(1991) in the ferret. ChAT immunoreactivity and TH immunoreactivity 
were used to localise cholinergic terminals and dopaminergic neurones 
respectively. In the SNPR there were few TH positive cells, but many TH 
positive dendrites from neurones in the SNPC. However, it was in the 
SNPC that ChAT positive boutons were observed to be apposed to TH
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positive dendrites most densely. Using both light and EM, cholinergic 
axons in the SNPR of the ferret were seen to make several synaptic 
contacts with TH positive dendrites. Many other non-ChAT 
immunoreactive boutons were seen to form synaptic appositions to SN 
neuronal dendrites demonstrating that the ACh input to the SNPC DA 
neurones represents only part of the input to SN neurones.
That a functional relationship does exist between the cholinergic 
nuerones of the PPTg and the DA-containing neurones of the SNPC was 
demonstrated by Blaha and Winn (In press). Using 
chronoamperometrometry, a technique which allows the in vivo 
measurement of dopamine release with a high temporal and 
neurochemical resolution when combined with a stearate-modified 
electrode, DA efflux in the CP was measured. Microinjection of the 
direct cholinergic agonists carbachol and nicotine and the cholinesterase 
inhibitor neostigmine increased DA release relative to baseline. A lesion 
of the neurones of the PPTg with quinolinic acid attenuated the response 
to neostigmine, but significantly increased the effect of intranigral 
nicotine. This suggests that the stimulatory effect on striatal DA efflux of 
intra-nigral neostigmine is caused by its prevention of breakdown of 
endogenous ACh released by terminals whose cell bodies are in the 
PPTg. Furthermore, because the lesion increased the effects of intra- 
nigral nicotine it is likely that the loss of ACh terminals in the SN has 
caused supersensitivity to develop in the cholinergic receptors known to 
exist on the DA-containing neurones of the SNPC.
Behaviour
Niijima and Yoshida (1988) investigated the behavioural effects of 
manipulation of the PPTg projection to the SNPC. They observed that 0.8 
g of kainate caused ipsilateral body flexion and circling, peaking 30 min
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post-injection (18 revs / min) which then decreased over the following 24 
hr. To test whether this rotation was mediated by DA they used the DA 
antagonist haloperidol (0.1 mg/kg and 0.5 mg/kg) injected systemically: 
this attenuated the rotation (59% and 92% respectively). Alpha- 
methyltyrosine (AMPT) inhibits TH, an enzyme which is vital to the 
synthesis of DA. Systemic injection of AMPT 6 hr before kainate 
abolished rotation (200 mg / kg, -96%). Noradrenergic antagonists had 
no effect on rotation to kainate. The muscarinic antagonist atropine 
sulphate (10 /^g) injected bilaterally into the VTA and SN reduced 
rotation to 32.7 / 30 min as compared to 128 / 30 min to saline before 
kainate. HPLC analysis allowed calculation of DA turnover in CP and 
NAcc from ratio of DA metabolites to DA; DOPAC + HVA / DA. DA 
turnover was increased in both the CP and the NAcc, and the increase 
was blocked by atropine sulphate in the NAcc but not the CP. The 
authors conclude that the kainate was transsynaptically stimulating the 
SNPC and VTA neurones.
Cholinergic control of midbrain DA-mediated behaviour
Although there is pharmacological and electrophysiological evidence for 
the presence of nicotinic and muscarinic receptors on the DA-containing 
neurones of the VTA (Clarke and Pert 1985, Grenhoff et al. 1986, Lacey 
et al. 1990), few studies have examined the behavioural effects of direct 
cholinergic stimulation of the mesolimbic DA system.
However, locomotion produced by administration of DA agonists into 
the NAcc can be replicated by systemic injections of nicotine in rats that 
have previous experience of the drug. Clarke et al. (1988) showed that 
increased locomotion was accompanied by an increase in DA utilization 
in the mesolimbic DA system as measured from tissue samples taken 30
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min after nicotine administration. The increase in locomotion was blocked 
by a bilateral 6-OHDA lesion of the NAcc.
The involvement of the PPTg in behaviours associated with mesolimbic 
DA is suggested by the production and blocking of conditioned place 
preference by the microinjection of nicotine and lesion of the PPTg 
respectively (Bechara and van der Kooy 1989; Iwamoto et al. 1983).
Smelik & Ernst (1966), having demonstrated compulsive gnawing in 
response to crystalline DOPA and apomorphine implanted in the CP of 
the rat, attempted to produce the same results with implantation of 
crystalline physostigmine (a cholinesterase inhibitor) in the SN. 
Compulsive gnawing was observed with a latency of 30 min and duration 
of 2 hr following 30 fig of physostigmine. This could be blocked with 
systemic atropine (a muscarinic antagonist). The authors concluded that 
the SN had a behaviourally important link to the CP that could at least in 
part be manipulated by muscarinic cholinergic stimulation of the SN. It 
should be noted, however, that atropine in addition to its action as a 
muscarinic antagonist also has a direct effect on neurones depressing 
activity.
Wolfarth et al. (1974) found injections of the direct DA agonist 
apomorphine (2 fig) to rabbit SN decreased locomotor activity, which is 
the opposite of its effect in the CP. Nigral carbachol (2 fig) induced 
locomotion, sniffing, head turning, ipsilateral rotation and epileptiform 
EÈG discharges. This suggests that Wolfarth was in fact 'overdosing' the 
animals. However, pre-injection with apomorphine attenuated the 
behavioural and abnormal BEG effects of carbachol. In a series of 
experiments the direct cholinergic agonists ACh and methacholine, and 
the indirect agonist neostigmine (a cholinesterase inhibitor), were injected 
bilaterally to SN. At 95 fig / nigra, ACh induced locomotion and EEG 
alerting for “25 min. At higher doses (475 fig f nigra) this lasted over 40
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min with epileptiform EEG discharges and body seizures. There was also 
sniffing and turning behaviour that was inteipreted by the authors as 
stereotypic behaviour. Methacholine and neostigmine had similar effects 
except that there was a longer delay before the behavioural effects of 
neostigmine appeared (20 min as compared to 5 min for ACh). This is 
what would be expected as its main stimulatory action is thought to be by 
allowing the accumulation of endogenous ACh by blocking the actions of 
AChE. It should also be considered that neostigmine also has direct 
stimulant effects on cholinoceptive neurones. The effects of methacholine 
were more prolonged than with ACh and the dosage at least an order of 
magnitude less than that of ACh required to produce an effect. This was 
thought to be because methacholine is not as strongly affected by AChE 
as ACh. As with Smelik & Ernst (1966) pretreatment with atropine 
blocked the behavioural effects of cholinergic stimulation. It was found 
that similar behavioural effects to cholinergic agonists were found with 
systemic injections of the DA agonists amantadine and apomorphine. Also 
the behavioural effects of neostigmine were blocked by pretreatment with 
spiroperidol (spiperone) the most potent of the antipsychotic neuroleptic 
drugs. Given the massive dosages Wolfarth used it is possible that what 
Wolfarth interpreted as stereotypy were in fact convulsions; repeated 
jerking movements that would satisfy most criteria for stereotypy. Such 
convulsions are most probably mediated by the nigrotectal pathway rather 
than the nigrothalamic or nigrostriatal pathways. Wolfarth suggests that 
the effects of cholinergic substances injected to SN are mediated by two 
different pathways, nigrothalamic and nigrostriatal. Furthermore she 
suggests that the effects of carbachol has opposite effects on the CP 
depending on which pathway is stimulated. This she concluded after 
injections to lateral (nigrothalamic) and medial (nigrostriatal) SN, but no 
further evidence has been produced to support this claim.
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Amt and Scheel-Kruger (1979) were interested in the mechanisms 
mediating GABA-stimulated contralateral turning in the SN. As described 
earlier, the turning following intranigral muscimol was attenuated by 
large doses of carbachol injected into the SN. These doses of carbachol 
alone produced postural assymetries and infrequent ipsilateral turning 
when administered to the rostral SN. The doses that produced these 
effects, 5 and 10 fxg carbachol, are larger than doses found to be 
behaviourally stimulating in studies in this laboratory, and indeed 
convulsions followed by death has been observed even at the 5 /ig dose. 
The NSP passes though the lateral hypothalamus, an area associated with 
the control of feeding. To investigate a possible role of the NSP in studies 
of feeding following manipulations of the lateral hypothalamus, Winn & 
Redgrave (1979) injected mixtures of ACh and physostigmine (2.5, 5.0 
and 10.0 fig of each) into the rat SN. They found a dose-dependent 
increase in consumption of spaghetti compared to saline and a significant 
negative correlation between consumption response and proximity of the 
injection site to medial SNPC. Cholinergic stimulation had no significant 
effect on drinking. In a second experiment, 0.5, 1.0 and 5.0 fig of 
carbachol increased dose-dependent increase in lever pressing for a food 
reward. The higher two doses of carbachol produced some cases of 
stereotypic gnawing and biting. These latter findings were replicated by 
Taha & Redgrave (1980) who found they could block the oral stereotypy 
caused by 5.0 fig carbachol by s.c. pretreatment with the DA antagonist 
haloperidol (0.4 mg/kg). Consumption of spaghetti in response to 0.5 fig 
carbachol was also abolished by s.c. haloperidol. It is interesting to note 
that the haloperidol did not just block the increase in consumption 
following carbachol, but abolished all feeding. This casts doubt as to 
whether the dose of haloperidol was specifically blocking effects of nigral 
stimulation or having a general effect on the animals ability to respond in
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a given situation, even though the dose of haloperidol used had no effect 
on locomotor behaviour. Winn and Redgrave (1981) observed dose 
dependent consumption of dry spaghetti with no effect on drinking using 
the indirect cholinergic agonist physostigmine sulphate injected into SN, 
and very similar results following systemic or microinjection to CP of 
low doses of d-amphetamine (Winn et al. 1982). It was also observed that 
doses of carbachol that did not induce locomotion in the presence of food, 
did so in its absence. These results taken overall suggested that 
stimulation of the nigrostriatal pathway might preferentially induce 
consumption of palatable food.
Winn et al. (1983) investigated this hypothesis in a series of experiments 
that also sought to discover whether cholinergic receptor blockade 
affected muscarinic cholinergic stimulation of SNPC. Behavioural 
analysis was made of eating, locomotion, sniffing, rearing and 
unconditioned responses to unilateral injection of carbachol to anterior 
SN. Having established a dose-dependent increase in consumption of dry 
spaghetti the experiment was repeated with wood chips instead of food.
There was no significant change in any behaviour including gnawing.
This suggests that the stimulation was not just preferentially but 
specifically consumption (as opposed to just gnawing). Finally, a similar 
increase in consumption was elicited using a mixture of ACh and eserine 
was blocked using the muscarinic antagonist atropine. This was 
interpreted as above to suggest that the cholinergic stimulation of SNPC 
is mediated by muscarinic receptors. Consumption of palatable food was 
also shown to be rate dependent in that increased feeding only occurred in 
those rats that had been allowed access to the food before injection. Rats 
that had not been exposed to the food pre-injection, and rats that been j
food-deprived did not show an increase in consumption following 
injection. 1
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Further studies have demonstrated behaviours other than feeding can be 
elicited by cholinergic stimulation of the SNPC. Winn (1991) found that 
male sexual behaviour was affected in quite a subtle manner. Intranigral 
carbachol had no effect on latency to mount, first intromission or first 
ejaculation. However, intromission frequency; calculated as latency to 
ejaculate divided by number of intromissions, was significantly reduced 
following intranigral carbachol. As discussed by Winn the significance of 
this is not clear but does represent more effort on the part of the male rat 
for the same latency to ejaculate.
In the same series of experiments, Winn also demonstrated that rats that 
have been pre-exposed to saccharin and tap water will increase their 
consumption of the palatable fluid with no increase in consumption of tap 
water following an intranigral injection of carbachol. Note that saccharin 
although having a very sweet taste has no food value, and hence the rats 
will have been responding to its taste rather than any calorific intake. 
Winn (1991) suggested that cholinergic stimulation of the SNPC can 
increase the performance of behaviours which the animal has a pre­
existing tendency to perform.
The evidence suggests that the DA-containing neurones of the SNPC 
respond to external, activating sensory stimuli and in some way influence 
the initiation or control of motor response to such stimuli. These neurones 
have both nicotinic and muscarinic cholinergic receptors and their activity 
is under a cholinergic influence from neurones whose cell bodies lie in 
the PPTg and perhaps also the LDTN. Previous studies have shown that 
microinjection of cholinergic agonists into the SN can influence behaviour 
in a manner that suggests there effects are mediated by the DA-containing 
neurones of the SNPC. The experiments presented in this thesis will 
investigate the functional significance of the cholinergic innervation of 
SN, demonstrate that the effects of this innervation are mediated by the
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DA-containing neurones of the SNPC and investigate the role of 
cholinergic control of midbrain DA neurones in the control of behaviour.
Surgery
Rats had chronic intracranial guide cannulae placed in the brain to allow 
repeated access to the same injection site with a thinner micro-injection 
cannula 2 mm longer than the guide cannulae. The co-ordinates targetted 
for the actual site of injection were therefore 2 mm lower than the co­
ordinates given for the placement of the guide cannulae in the two 
orientations described below.
Orientation o f Level Skull
Placed in a stereotaxic frame with the incisor bar set for level skull. 
Using co-ordinates from Paxinos and Watson (1982): SN (interaural line 
(lAL) -h3.8 mm, Lateral 4%2.2 mm. Vertical -5.5 mm); and the LHA 
(Bregma -2.3 mm, Lat. ± 2 .0  mm. Vert. -5.5 mm).
Orientation o f De Groat
Placed in a stereotaxic frame with the incisor bar 5.0 mm above the 
interaural line. The stereotaxic co-ordinates were SN: (Bregma -2.8 mm, 
Lat ± 2 .0  mm, Vert -5.5 mm); VTA: (Bregma -2.6 mm, Lat ± 1 .0  mm. 
Vert -5.5 mm).
Chronic cannulation
The rats were implanted with 11.5 mm stainless steel guide cannulae (23 
ga), roughened beforehand to ensure purchase. These were secured using 
dental cement and skull screws. The cannulae were kept patent by the 
presence of removable 30 ga stylets.
Test procedure
The group of rats for testing were left for 1 hr in the test cages with 
weighed amounts of whatever was being consumed. Each animal was in
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turn removed from its cage to receive a microinjection of drug or just
vehicle solution depending on the condition. This was delivered by a 13.5 I
'Imm 30 ga stainless steel cannula connected to a 10 ^1 SGE syringe 
propelled by a Harvard infusion pump at a rate of 0.5 /il. min"^ for 60 
sec. The injection cannula was left in place for a further 30 sec to ensure 
the diffusion of the drug away from the cannula tip. The animal was then 
returned to its cage.
The order of administration of drugs was counterbalanced with a 
minimum of 48 hr between injections.
Vi
Direct cholinergic agonists used 
Carbachol (carbamylcholine chloride) is a cholinergic agonist known to 
have agonistic effects at muscarinic receptor sites. It is now also known to |
have effects at nicotinic receptor sites but this is thought to be at a î;
different dose range to its effects as a muscarinic agonist (Rang and Dale 
1987, p. 119). This agonist was used in this thesis as an extension of $
previous work which had used it as a muscarinic agonist (Winn et al.
1983). However, the possibility of its actions being also being mediated 
by nicotinic receptors does exist. In the last few years there has been an 
increasing literature on receptor sub-types and the specificity of agonists 
and antagonists. Carbachol should now be regarded as a useful 
cholinergic agonist, but not the ideal choice as a specific muscarinic 
agonist. There now exists specific Ml receptor agonists such as McN A 
343, and it is likely that agonists specific for further muscarinic receptor 
sub-types will be available with further research.
Nicotine (nicotine hydrogen tartrate) is the classic nicotinic agonist and is 
thought to have no effect on muscarinic binding sites.
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Post-hoc analysis
Statistically significant main effects and interactions were then further 
analysed using Newman-Keuls test for multiple comparisons.
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Statistical analysis 
Analysis o f Variance 
Almost all of the data produced in this thesis were analysed 
parametrically using analysis of variance. The design of most of the i
experiments was of repeated measures. This being a special example of a 
multivariate ANOVA with the dependent variables being different levels 
of the same Within Subjects Factor, the analysis was performed on the 
PC version of SPSS using the MANOVA command with the 
WSFACTOR sub-command.
1
Animal euthanasia
The animals used were killed by either stunning followed by |
decapitation or by perfusion. This consisted of an overdose of sodium
pentobarbitone (0.4 ml.kg"^) then perfused transcardially with saline
followed by 300 ml fixative (4% parafbrmaldehyde/0.05% |
gluteraldehyde, in 0.1 M phosphate buffer). The brains were stored in 
fixative solution.
Histology
The brains having been stored in formalin for at least 24 hr were cut 
using a freezing microtome. The slices were 40 u thick and mounted on 
lumps of glass for subsequent staining with cresyl violet and studied 
under a Leitz 'Diaplan' microscope.
4 Direct and indirect cholinergic stimulation of anterior SN 
Introduction
Microinjection of cholinergic substances into the rat anterior SN 
produces dose-dependent increases in activities for which the animal has 
both a low baseline rate and a positive predisposition (Winn et al. 1983; 
Winn 1991). Increased eating of spaghetti but not lab chow has been 
observed in satiated rats following microinjection of the muscarinic 
agonist carbachol (Winn et al. 1983), the AChE inhibitor eserine (Winn 
and Redgrave 1981) and mixtures of ACh and eserine (Winn and 
Redgrave 1979). This latter response was blocked by pre-injection into 
the SN of the muscarinic antagonist atropine, suggesting that it was 
mediated by muscarinic rather than nicotinic cholinergic receptors (Winn 
et al, 1983). Similarly, increased drinking of saccharin solution, but not 
water, has been shown in satiated rats following microinjection of 
carbachol, which has been shown also to affect sexual behaviour in male 
rats (Winn 1991). However, those doses of carbachol which affect food 
intake (0.1 and 0.5 /tg/0.5 /il) appear to have no effect on other 
unconditioned activities such as gnawing, locomotion, grooming, sniffing 
or rearing (Winn et al. 1983; Winn 1991).
Previous psychopharmacological work has concentrated on cholinergic 
stimulation using the direct muscarinic agonist carbachol, but the presence 
of nicotinic receptors and cholinergic terminals suggests there may be 
differing effects of cholinergic activity depending upon which class of 
cholinergic receptor is stimulated. It has been suggested that ACh acts as 
a 'fast' neurotransmitter through the nicotinic receptor and as a 'slow' 
neurotransmitter through the muscarinic receptor (Kemp et al. 1977). 
Nicotinic cholinergic stimulation would be of a prescribed excitatory 
nature whereas muscarinic stimulation could be excitatory, inhibitory or it
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could act to potentiate the neuronal membrane with respect to further 
binding by other molecules. It is therefore appropriate to make a direct t
comparison between microinjection of a direct muscarinic agonist, a 
direct nicotinic agonist and AChE inhibitors (which should reveal the 
effects of endogenous ACh) into the anterior SN. Hence, in the present 
experiments the actions of carbachol were compared with those of 
nicotine, eserine and neostigmine. The potency of action of neostigmine 'A
has not been well explored. There were therefore two ranges of doses 
used for this drug. Feeding and drinking were both measured, and a 
detailed assessment of other unconditioned activity including grooming, 
locomotion, gnawing and elements of exploration was carried out.
Methods 
Animals 455 rats with mean body weight at the time of surgery 259.7 g (SE = JH2.06) were used.
Stereotaxic surgery
Rats were anaesthetized with Avertin and placed in a stereotaxic frame 
in the orientation of De Groot. The rats were implanted unilaterally with 
cannulae terminating above the anterior SN.
Intracranial drug administration
The rats were arbitrarily assigned to one of five drug groups and 
received the following doses and the vehicle solution sterile saline: 
carbachol 0.1, 0.5, 5.0 fig; nicotine 0.1, 0.5, 5.0 fig; eserine 2.5, 5.0,
10.0 fig; neostigmine 0.1, 0.5, 1.0 fig; or neostigmine 1.25, 2.5, 5.0 fig.
Test procedure
Following recovery from surgery, the rats were habituated to the test 
cages and procedure. Rats were observed in individual cages with
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sawdust-covered floors for 60 min prior to and 60 min following |
microinjection. During the habituation and test sessions rats had free |
access to weighed amounts of tap water, normal lab chow, dry macaroni 
(1470 Kj/100 g, 13.0 g protein/100 g) and polystyrene packing chips.
Rats were transferred to fresh, provisioned cages every 30 min to monitor 
consumption during the test period before and after microinjection.
Behavioural analysis 
Each rat's behaviour was quantified by the method of Fray et al. (1980).
The observer, who was blind to which drug and dose the rat had 
received, recorded the presence of the following responses every 5 min in 
a 10 sec observation period:
(a) still/asleep: lying or sitting; not engaged in any activity.
(b) locomotion: all 4 legs moving for > 3 sec.
(c) rearing: both forepaws raised from the cage floor.
(d) sniffing for > 3 sec.
(e) grooming (forepaw): grooming of the face and head with the fbrepaws i  
for > 3 sec.
(f) grooming (other): grooming other than that in (e) for > 3 sec.
(g) gnawing polystyrene chips for > 3 sec.
Statistical analysis
Food and water intake data were analysed by analysis of variance vj
(ANOVA). The data for each drug group was analysed separately with 
dose (saline and three doses of drug) and time (0-30 min and 30-60 min 
post-injection) being repeated measures. Post-hoc analysis was made with 
Newman-Keuls test for multiple comparisons. The remaining behavioural 
data, although collected by the observational method of Fray et al.
(1980), could not be analysed using the method of those authors (the 
Information Statistic). This requires that all measures be independent, but
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the data in the present study involved repeated measures, each animal 
serving as its own control. The control mean and standard deviation for 
each behavioural category was calculated from the saline data of each of 
the 5 drug groups independently for the first 30 min and first 60 min 
post-injection. The numbers of rats in the drug conditions scoring > 1 SD 
and >2 SD above the control mean was tabulated.
Results
Histology
Cannula placements were verified post-mortem and Figure 12 presents 
representative sections showing these. Following histological 
examination, 46 rats were found to have injection sites in or immediately 
rostral to SN. The close association between SNPC and SNPR formed by 
the descending dendrites of PC DA neurones means that an injection site 
in PR will affect the dendrites of PC neurones. Those rats found by 
histological inspection to have misplaced cannulae - that is outside the SN 
- were excluded from the behavioural analyses and are shown on Figure |
12 as misplaced cannulae. Although no formal examination was made, 
inspection of the histology suggests that there were no differences in 
cannulae placements between drug groups. Two rats not included in the 
analyses died following convulsions after the highest dose of neostigmine.
Eating and drinking in response to cholinergic stimulation 
Analysis of the consumption of macaroni (see Figure 13) after injection 
of carbachol revealed a main effect of dose (F=4.77 df—3,30 p<0.01) 
but no effect of time (F=1.98 df—1,10) and no dose x time interaction 
(F=2.59 df—3,30), Similarly, nicotine produced a main effect of dose 
(F==3.52 df—3,21 p <0.03) but not time (F=3.32 df~ 1,9) and no dose x 
time interaction (F—0.29 df—3,27), The low dose range of neostigmine 
produced a main effect of dose that approached significance (F—3.22
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Figure 12: Représentative sections, redrawn from the atlas o f Paxinos and 
Watson (19B2) showing nigral (% ) and misplaced (à .)  cannulae. Figure 
A shows those injection sites for rats receiving carbachol and nicotine. 
Figure B (over) shows neostigmine and eserine. The placements o f 
cannulae delivering the different drugs are shown separately, collapsed 
onto right or leji hemispheres. The neostigmine placements show both 
high and low doses.
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Figure 12: See legend on previous page for details
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4/^3,15 ;?=0.053), no main effect of time (F—5.60 df—\y5) but a dose 
X time interaction (F=5.12 (^'=3,15 /?<0.02). Eserine showed no main 
effects of dose (F—0.38 (ÿ=3,30), time (F=1.09 <ÿ==l,10), or 
interaction (F=0.63 4^—3,30). The high dose range of neostigmine 
showed a significant main effect of dose on macaroni consumption 
(F=6.02 4^=3,21 p < 0.005), no main effect of time (F=0,75 4^—1,7), 
but a significant dose x time interaction (F=4.36 df—3fL\p<0,02).
Post-hoc analysis revealed significant effect of dose of carbachol ï
collapsed over 0-60 min between saline and 0.5 pg (p<0.01). For 
nicotine, there were significant differences between saline and 0.5 pg 
(p<0.05). The dose x time interaction in response to low doses of
;
neostigmine revealed a significant difference between saline and 0.1 pg j
over 0-30 min (p<0.05). The effect of 0.1 pg neostigmine was greater |
over the 0-30 min than 0.5 pg and 1.0 pg (p<0.05 and /><0.01
respectively), and greater than 0.1 pg over 30-60 min (^<0.01). Within 
the higher dose range of neostigmine, there was a significant decrease in 
eating after 5.0 pg neostigmine compared to saline (p<0.05) collapsed 
over 0-60 min. The significance of the dose x time interaction was 
between the control dose over 0-30 min compared to all other doses and 
time periods (all/><0.01).
Consumption of lab chow was negligible, occurring only in small 
quantities (<  0.2 g) in only 8 out of 456 tests, following stimulation by 
the highest doses of neostigmine and carbachol. Analysis of the .{
consumption of tap water revealed no effect of dose for any drug group '
(carbachol: F -0 .03  4^=3,30; nicotine: F=0.94 4^= 3,27; low
neostigmine: F —1.23 df—3,15; eserine: F—OJO df—3,30; high i,;
neostigmine: F —0.53 df—3,2\).
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Figure 13: Mean (±SE) amount of food (dry macaroni) consumed in (F30 
and 30-60 min following unilateral microinjection o f cholinergic agonists 
into the SN, data in panel shows significant effect o f dose p  <0.05)
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Behavioural analysis
Examination of still/asleep, locomotor, rearing, sniffing, gnawing of 
polystyrene chips and grooming responses was made (data not shown). 
The only differences between the drugs occurred with the highest dose of 
carbachol and the higher doses of neostigmine. No dose of nicotine, 
eserine or the lower doses of neostigmine had effects different to saline in 
any behavioural category. The high dose of carbachol increased rearing in 
5 out of 11 rats and the highest doses of neostigmine increased rearing 
and sniffing in (at most) 6 out of 8 rats. (This proportion was not 
increased by relaxing the criterion level to > mean +  1 SD above 
control: 2 rats showed no difference in their responses to high doses of 
neostigmine and saline). Other forms of behaviour observed included 
ipsilateral turning, and scrabbling with the forepaws and cage-bar 
gnawing following high doses of neostigmine. Seizure-related activities 
(wet dog shaking and convulsions) were seen following 5.0 jitg carbachol. 
Two rats not included in the analyses died following convulsions after 5.0 
pg neostigmine.
Discussion
Microinjections of carbachol, nicotine and the low dose range of 
neostigmine all elicited dose-dependent increases in the consumption of 
palatable food when injected into the anterior substantia nigra. Carbachol 
and nicotine elicited significant dose-dependent increases in feeding over 
0-60 min post-injection while neostigmine was significant only over the 
first 30 min; no dose of eserine increased feeding. The high dose range of 
neostigmine decreased feeding compared to saline. High doses of 
carbachol and neostigmine in some rats increased the frequency of 
sniffing and rearing, activities which had no apparent goal. Nicotine, and
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the lower doses of carbachol and neostigmine, did not affect activity other
than eating, while eserine was without clear effect. I'1
The lowest dose of neostigmine, but no doses of eserine, increased J
feeding. Although the differences in chemical composition between the |
two molecules have been described, how such differences affect the |
pharmacological actions in the central nervous system are not well -p
understood. The doses of eserine used here were taken from a previous |
study (Winn and Redgrave 1981) in which dose-dependent feeding was 
obtained following microinjection of eserine into the SN. The difference 
between those results and the present ones may be explained by the 
variable actions of eserine: in every rat tested here a dose of eserine was 
found which stimulated more eating than control but which dose and at 
what time post-injection varied considerably between rats, making mean 
levels of consumption difficult to discriminate. We have not attempted to 
analyse the eserine data by selecting those doses which appeared to work 
in individual rats and comparing them to control because the effects of no I
other cholinergic agent required such analysis. Presumably, the variable 
effects of eserine reflect some pharmacological difference between this 
and neostigmine. In the periphery, studies have shown that eserine but not 
neostigmine blocks ACh release (Alderdice 1979), which would be 
counter-productive in the present experiments, and that neostigmine has a 
direct nicotinic stimulatory effect which eserine does not (Bowman and 
Rand 1980 p. 10.21). The possibility that the effects of neostigmine were 
due to direct stimulation of nicotine receptors is however unlikely: it has 
been shown that lesions placed caudal to SN in the PPTg greatly attenuate 
the stimulatory effects of neostigmine but enhance the effects of nicotine 
(Blaha and Winn, In press).
The highest dose of neostigmine actually decreased consumption of 
macaroni compared to saline. Such a decrease in feeding with increasing
;
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dose is also apparent with the direct cholinergic agonists carbachol and |
nicotine. That the highest doses of the direct cholinergic agonists did not |
produce a decrease in feeding compared to saline reflects differences in 
the range of doses used. Previous studies have shown that doses of direct 
agonists higher than those used here can attenuate feeding (Winn et al. #
1983). The highest dose of neostigmine produced lethal convulsions in tÿ
two of the subjects, as has also been observed in the past following high 
doses of carbachol.
The effects of nicotine and carbachol were, in this study, 
indistinguishable. Examination of other forms of behaviour may reveal 
differences between nicotinic and muscarinic activation, or different 
interactions between each of these and stimulation of other receptors 
present on SNPC neurones. The effects of neostigmine did not differ in 
any significant manner from carbachol. This is consistent with the 
hypothesis that neostigmine-induced blockade of AChE potentiated the 
action of endogenous ACh facilitating its action at cholinergic receptors in 
SNPC.
A body of evidence now suggests that the effects of cholinergic 
stimulation of the anterior SN are mediated by nigrostriatal DA- 
containing neurones. It has been thought that CP DA mediates many of 
the effects of amphetamine, including the behavioural stereotypies 
produced by higher doses of this drug. Such a conclusion is supported by 
lesion studies (Kelly et al. 1975) and by recent demonstrations of oral 
motor stereotypies following dopaminergic stimulation of the ventrolateral 
striatum (Delfs and Kelley 1990; Kelley et al. 1988). In agreement with 
previous studies however (Winn et al. 1983; Winn 1991) no stereotypy 
was observed following cholinergic stimulation of SN. The high doses of 
neostigmine did produce an increase in the frequency of sniffing and 
rearing, all but two rats showing frequencies greater than the saline mean
-, *------------------------------------------------------------- -   ?... : - ; x . 2
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+ 2SD. However, the relationship between this and the stereotypy 
produced by amphetamine is not clear. Amphetamine treated rats tend to 
show sniffing, rearing and locomotion (3 on the Creese-Iversen scale, 
Kelly et al. 1975), these giving way at higher doses to "head down" 
sniffing maintained in one location, usually the comer of the cage. 
Neostigmine treated rats on the other hand, showed little increase in 
locomotion and no "head down" sniffing. Their behaviour may have had 
as much in common with the development of seizures as with 
stereotypies.
The size of the CP and its pattern of innervation by nigrostriatal DA 
make direct investigation of its role in striatal function difficult. The CP 
has a neurochemical and cytoarchitectonically heterogeneous structure. 
Lowenstein et al. (1990) found a greater number of DA terminals in the 
matrices than in the patches of the CP, but that D1 receptors are found 
predominantly in the patches (Besson et al. (1988). Administration of 
direct DA agonists into the CP will not correctly replicate the 
topographical distribution of DA release that occurs from nigrostriatal 
terminals. By stimulating DA release by injections to the SN one can be 
confident of releasing DA in both a physiologically and topographically 
relevant manner. It could be argued that the problems of administering 
direct agonists to the CP should also apply to the SN. However, our use 
of the indirect agonist neostigmine ensures that the normal topographical 
distribution of ACh stimulation, if not the normal physiological level, as 
released from ACh terminals is preserved.
Thus we have a powerful tool for investigating the dopaminergic 
influence of the SN on the CP and furthermore a means for bracketing 
this stimulation within the physiological limits set by its pontine tegmental 
afferents.
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5 Behavioural specificity of cholinergic stimulation of anterior SN 
Introduction
The previous experiment showed that cholinergic stimulation of SN 
produces a dose-dependent increase in feeding to palatable food to which 
tlie animal has been pre-exposed. The rats showed no increase in drinking 
to tap water. It had been suggested that cholinergic stimulation of SN 
might specifically stimulate eating behaviour (Winn et al. 1983). 
However, increased drinking behaviour has been observed following 
nigral stimulation in the presence of saccharin solution (Winn 1991). It is 
therefore appropriate to seek to replicate the findings of Winn (1991) 
using a different, but still palatable liquid. Rats will drink up to ten times 
as much ’Ribena' as water over an hour. This experiment therefore 
investigates whether cholinergic stimulation of SN can increase drinking 
to a palatable fluid to which the animal has been pre-exposed.
Methods
Animals
12 rats with mean body weight at the time of surgery 258.4 g (SE = 
3.18) were used.
Stereotaxic surgery
Rats were anaesthetized with Avertin and placed in a stereotaxic frame 
in the orientation of Level Skull. The rats were implanted unilaterally 
with guide cannulae terminating above the anterior SN.
Intracranial drug administration
Each animal received a unilateral microinjection of 0.5 pg carbachol in 
0.5 pi sterile saline, and saline alone, to the nigral cannula in a 
counterbalanced order.
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at 60 min post-injection.
Results
Histology
It was decided that any site showing less drinking to carbachol than to 
saline should be retested using a longer micro-injection cannula in an 
attempt to locate an ’active’ site. This consisted of increasing the cannula 
length by 0.5 mm and repeating the testing as described above.
As can be seen from Figure 14, the sites of injection for each animal 
passed through SN to the crus cerebri below. As each animal was re­
tested three times at progressively lower depths, 0.5 mm each time, the 
injection sites would have been in SN for at least one of the testing 
sessions.
Drinking in response to cholinergic stimulation 
Figure 15 shows volume of ribena drunk in response to carbachol and 
saline. There was no difference in drinking (T==0.23, df = 1,11 J3<0.82) 
between the two conditions.
Test procedure
Rats were placed in individual cages with weighed bottles of ribena 
made up to 20% with tap water. The group of animals for testing were 
left for 60 min to drink ribena before microinjection. Each bottle was 
then removed and its weight noted. The weight of each bottle was noted 1
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Figure 14: Representative sections showing deepest injection sites ( t k)  in 
the crus cerebri following repeated injections at progressively lower 
depths through SN.
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Figure 15: Mean (±SE) amount o f ribena consumed (ml) in 60 min 
following injection o f carbachol and saline into anterior SN
Amount drunk (ml)
Saline Carbachol
I
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Discussion
As drinking to a palatable fluid such as ribena begins with a high 
frequency then gradually diminishes over time, it would be predicted that 
such behaviour could be stimulated by microinjection of cholinergic 
agonists into the SN (Winn 1991). Increased drinking has been shown 
previously to saccharin solution, and there is no doubt that the rats find 
the ribena palatable. In testing consumption of palatable food, there is a 
pattern to the response to carbachol as compared to vehicle solution as the 
site of injection moves downwards towards the nigra: when the site of 
injection is above the SN the level of feeding will be higher following 
saline than carbachol; then the same as carbachol; and when the site is in 
SN there will be an increase in feeding following carbachol compared to 
saline. Such a pattern did not occur in response to ribena. It is possible 
that the level of stimulation caused by a unilateral injection of 0.5 ug 
carbachol is not enough to produce the increase in consumption of |
palatable fluid. Although previous unilateral studies have shown increase 
consumption of palatable food, the Winn study using saccharin used 
bilateral injections.
Winn (1991) found increased drinking to a palatable fluid, saccharin.
Saccharin, unlike ribena has no calorific value. It has been demonstrated 
that glucose has an effect on the metabolism of DA in the CP and it is 
possible that the actual behaviour being measured in response to 
cholinergic stimulation of DA release is itself having an effect on DA 
action in the CP independent of any rewarding properties the consumption 
of the palatable fluid might have. The effects of intranigral carbachol on :j
feeding to palatable food was shown by Winn et al. (1983) to be rate i
dependent, food deprived or rats that had not been pre-exposed to the , i
.''■■Ifood did not demonstrate increased feeding to cholinergic stimulation. It i
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is possible that stimulation of consumption following intranigral carbachol 
is dependent on the activational potential of the behaviour in a manner 
analogous to the dependency of the effect on the baseline rate of eating. 
The previous study showed no increase in consumption of lab chow 
following carbachol. A stimulus that is highly activating may also be 
unaffected by the addition of stimulation caused by intranigral carbachol. 
Given that increases in firing rate of nigrostriatal DA neurones is 
associated with the presence of stimuli that are described as activating 
(Chiodo et al. 1980), it is possible that the presence of glucose is an 
extremely salient and powerful influence and that the additional 
stimulation caused by intranigral carbachol does not produce a 
behaviourally observable effect on nigrostriatal DA activity.
Alternatively, Ribena, while being extremely palatable, might not cause 
the feeling of satiation that occurs with the consumption of pasta in the 
previous experiment. Furthermore, the urination of unwanted fluid might 
make the condition of satiation less certain than in response to feeding.
Chiodo et al. (1980) showed that SN DA-containing neurones increased 
their firing rate following tail-pinch. As discussed by Robbins and Fray 
(1980), tail pinch can induce increased feeding, but not increased 
drinking of water. Although drinking of milk can follow tail-pinch, that 
could be argued to be ingestion of a food. It appears that the neurological 
systems underlying feeding and drinking are under different controls and 
influenced by differing factors and hence cholinergic stimulation of 
drinking may not be elicited in the same manner as feeding.
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6 Muscarinic and nicotinic stimulation of anterior SN 
Introduction
Behaviour for which there is a pre-existing tendency to perform at high 
frequency at first exposure, but is being performed currently at a low 
frequency, can be stimulated by administration of either nicotinic or 
muscarinic agonists to SNPC. It is of interest to know how stimulation of 
the two subtypes of cholinergic receptor interact, and to see whether such 
an interaction would produce discernible effects at the behavioural as well 
as pharmacological level. In chapter 4 there were no significant 
differences in effect on behaviour between nicotinic and muscarinic 
stimulation. The investigation of the cholinergic projection from the pons 
to the SNPC has yielded good evidence of a functional cholinergic 
innervation of SNPC DA neurones (Gould et al. 1989, Blaha and Winn, 
In press). But as yet no study has demonstrated the relationship between 
the cholinergic innervation and muscarinic and nicotinic receptors known 
to exist on the DA neurones. However, it seems likely that the target sites 
of ACh released by terminals in the SN would include both muscarinic 
and nicotinic cholinergic receptors.
There is presumably a functional reason as to why there should be two 
types of cholinergic receptor in the brain, and to this investigation 
especially, on the post-synaptic membranes of NSP DA neurones. It is 
now generally accepted that there is a cholinergic innervation of the SN 
from the pons. There is a clearer picture forming of the anatomical 
relationship between the pons and the mesencephalon, but little functional 
characterisation of the nature of this innervation. Given that previous 
experiments have shown a similar behavioural effect in response to both 
muscarinic and nicotinic stimulation, it is plausible that endogenous ACh, 
released from the terminals of pontine cholinergic neurones in the SNPC
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can act at both types of receptor to change the state of SNPC DA 
neurones. The functional relationship between effects mediated at 
nicotinic and muscarinic receptors has not previously been investigated. 
This investigation therefore begins to characterise the relative contribution 
of the two sub-types of cholinergic receptor to the overall effect of 
cholinergic influence on NSP DA neurones. To investigate the 
relationship between nicotinic and muscarinic activation the present 
experiment will examine firstly the effects of carbachol and nicotine over 
a range of doses, and secondly the effect of adding the most effective 
dose of carbachol to the dose response curve to nicotine. This will allow 
us to begin to characterise the contribution to overall cholinergic 
stimulation made by each receptor type.
Methods
Animals
44 rats with mean body weight at the time of surgery 259.7 g (SE =
2.06) were used.
Stereotaxic surgery
Rats were anaesthetized with Xylazine and Ketamine and placed in a 
stereotaxic frame in the orientation of De Groot. The rats were implanted 
unilaterally with cannulae terminating above the anterior SN.
Intracranial drug administration
The rats were arbitrarily assigned to one of three drug groups and 
received the following doses: carbachol 0, 0.039, 0.1, 0.257 ^g; 
nicotine, 0, 0.055, 0.1, 0.25 /xg; most effective dose of carbachol + each 
of the above doses of nicotine.
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Test procedure
Rats were placed in individual cages with free access to weighed 
amounts of tap water, normal lab chow, dry macaroni (1470 Kj/100 g,
13.0 g protein/100 g) and polystyrene packing chips for 60 min before 
and after administration of drug to the nigral cannula.
Statistical analysis
Food and water intake data were analysed without transformation by 
analysis of variance (ANOVA).
Results
Histology
Cannula placements were verified post-mortem and Figure 16 presents 
representative sections showing these. Following histological 
examination, 34 rats were found to have injection sites in or immediately 
rostral to substantia nigra.
Feeding to cholinergic stimulation
Figure 17 shows the mean intake of dry macaroni over 60 min following 
microinjection of cholinergic agonists: Figure 17 (A) shows the dose 
response to carbachol. Figure 17 (B) the effect of adding the most 
effective dose of carbachol, 0.1 ug, to the dose response to nicotine. Both 
carbachol (F=3.99, xÿ* 3,24, p<0.02) and nicotine (F=7.07, xÿ" 3,33 
/7<0.01) alone produced significant dose-dependent increases in 
consumption of macaroni.
Injections of carbachol + nicotine showed a significant main effect of 
dose (F=5.32, 3,30, 0.005). Comparison of carbachol 4- nicotine
with nicotine alone showed a significant main effect of
Figure 16: Representative sections showing nigral (%) and misplaced (âk)
cannulae
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Figure 17: Mean (±.SE) amounts o f dry macaroni consumed in 60 min 
following injections o f (A) carbachol, (B) nicotine, and carbachol + 
nicotine
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drug (F-7.01, <;/l,23,p<0.015) and dose (F-9.79, rf/3,69, p < 0.001) 
but no drug x dose interaction (F= 1.97, <ÿ'3,69).
Discussion
It is clear that stimulation with either a nicotinic or muscarinic agonist 
increased consumption of palatable food to which rats had been pre­
exposed. Addition of a reliably stimulating dose of carbachol had an 
additive effect with nicotine. These data are consistent with the previous 
study that showed increased feeding in response to intranigral carbachol, 
nicotine and the anticholinesterase neostigmine but adds to that study by 
demonstrating that, at the doses used here, nicotinic and muscarinic 
stimulation can have additive effects. It should be noted that the dose 
response curve of consumption of palatable food following carbachol + 
nicotine showed a main effect of dose. This demonstrates that the 
response to nicotine was not overwhelmed by the addition of carbachol: 
the various doses of nicotine had discriminable effects following addition 
of carbachol. This suggests that the effects of muscarinic and nicotinic 
stimulation are truly additive, in that the nicotinic cholinergic stimulation 
produced dose dependent effects even in the presence of carbachol. The 
effect of adding carbachol was to elevate baseline responding.
Consumption of lab chow and water 
Consumption of lab chow occurred infrequently (24/136 tests) and in 
negligible quantities. Carbachol did not stimulate consumption of tap 
water (F=1.13, d f 3,24) but drinking after administration of nicotine did 3
approach (though not achieve) statistical significance (F=2.43, d f  3,33 
/?< 0.083). Addition of carbachol to nicotine also produced no main I;
effect on drinking of drug (F-0.00, <yi,23), dose (F-2.07, d f 3,69) or 
interaction (F—1.75, d f 3,69). The amount drunk ranged from 1.44 to 
2.5 ml.
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Although these results are suggestive of an additivity of effect at the |
doses of carbachol and nicotine used, a more fuller investigation would 
include a dose response curve for carbachol with a fixed dose of nicotine 
added. This would allow a more stringent assessment of whether the two 
drugs can be truly be said to be additive in their effects. However, a more 
precise investigation of the relationship of the muscarinic and nicotinic 
stimulation of SN would more appropriately be carried out at a different 
level of analyisis from the behavioural level used in the present study.
These results suggest that additivity is possible in the stimulation of both 
types of cholinergic receptors, but a more sensitive measure of the 
activity of SNPC DA-containing neurones would be required in a Schild 
analysis to demonstrate true additivity. Although the Schild analysis 
allows the measurement of biological responses to relate agonist-receptor 
effects, feeding behaviour would be a very noisy measure. 
Electrophysiological measurement of neurone activity, or even 
electrochemical detection of DA release in the CP would be more 
appropriate measures.
These results are consistent with the fact that both types of receptor are 
present on DA-containing neurones in the SNPC and that stimulation of 
each excites these neurones (Blaha and Winn, In press; Lacey et al.
1990), increasing DA efflux in the ipsilateral CP. Carbachol is now 
known to act over a certain dose range as an agonist at nicotinic as well 
as muscarinic cholinergic receptors (Norris et al. 1992). However it is 
clear from our results that the stimulation resulting from addition of 
carbachol to nicotine is significantly greater than could be achieved with 
any dose of nicotine. Were the effects of carbachol mediated by nicotine 
receptors alone we would expect to see similarly elevated levels of 
behavioural stimulation at the highest dose of nicotine.
I
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The concept of ’fast' and 'slow' neurotransmitter has been used to #
differentiate the actions of those neurotransmitters opening ion-channels 
over a period of only msecs from others that act through second 
messenger systems over a period of secs or longer. Kemp et al. (1977) |
suggested that ACh acts as a fast neurotransmitter at nicotinic receptors 
and as a slow neurotransmitter at muscarinic cholinergic receptors. The $
binding of two molecules of ACh with the nicotinic receptor complex 
results in the opening of the ion channel associated with each receptor.
This will induce changes in the permeability of the membrane to Na*^,
K*^  and Ca^"^. The Na“*“, which is in a higher concentration outwith the 
cell, flows inwards, as to a lesser extent does Ca^*^, while K*  ^ which has |
a higher concentration inside the cell flows outwards (Bowman and Rand 
1980). Weiner et al, (1990) have used molecular cloning techniques to 
demonstrate that of the five types of muscarinic receptor that have been |
described on the basis of molecular structure, only the m5 receptor sub- 
type is present on SNPC neurones. The m5 receptor is thought to ^
conform to the M l receptor described by pharmacological studies 
(Buckley et al. 1989). Lacey et al. (1990) found that the effects of 
muscarine on SNPC DA neurones had the same effect as the Ml 
muscarinic agonist pirenzepine. The association of the Ml receptor 
subtype with SNPC DA-containing neurones was further confirmed by 
Nastuk and Graybiel (1991) who, also report M2 binding sites in the SN 
following autoradiographic analysis. Ml receptors stimulate 
phosphoinositide hydrolysis and inhibit cAMP production. The hydrolysis 
of triphosphoinositol (inositol 1,4,5-triphosphate) releases Ca^*^ from 
intracellular stores that will depolarize the membrane and thus increase 
the probability of the threshold of excitation for that neurone being 
reached. Thus ACh has a chimeric ability to act as both a slow and a fast 
neurotransmitter on possibly the same DA neurones in the SNPC. One
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conceivable functional reason for this could be that ACh has a 
straightforward stimulatory action on the SNPC DA neurones mediated 
by nicotine receptors, while the action at the muscarinic receptors not 
only stimulates increased firing of the neurones but also effects the 
membrane response and affinity to the binding of future ACh molecules 
and that of other neurotransmitters afferent to the SNPC.
Investigations of cholinergic-dopaminergic interactions in the basal 
ganglia have previously focussed on the striatum. However, pontine 
cholinergic neurones innervating midbrain DA-containing neurones are 
able clearly to increase the activity of nigrostriatal and also 
mesoaccumbens systems. This has implications for transplant studies 
using animal models of parkinsonism. Tliese results might explain why 
there is only partial recovery of function produced by striatal implants of 
nigral cells into a rat model of hemiparkinsonism (Dunnett et al. 1981). 
The failure to reinstate normal feeding behaviour may well reflect the loss 
of appropriate control of striatal DA efflux associated with activating 
stimuli (Chiodo et al. 1979) and cholinergic influence on nigrostriatal DA 
activity.
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7 The nigrostriatal pathway and cholinergic stimulation of SNPC 
Introduction
The behavioural effects of microinjecting cholinergic drugs into the SN 
are thought to depend on stimulation of DA-containing neurones in the 
pars compacta. Four lines of evidence support this: (i) the strength of the 
behavioural response to cholinergic stimulation has been shown to be 
proportional to the proximity of the injection site to the SNPC (Winn and 
Redgrave 1979); (ii) microinjection of d-amphetamine into the CP, which 
causes efflux of DA from NSP terminals, causes increases in eating 
(Winn et al. 1982); (iii) systemic injections of non-sedative doses of the 
DA antagonist haloperidol block behaviour stimulated by injection of 
carbachol into SNPC (Taha and Redgrave 1980); (iv) both muscarinic 
(Cross and Waddington 1980) and nicotinic (Clarke and Pert 1985) 
cholinergic receptors have been localized to nigrostriatal DA neurones.
Although the evidence strongly suggests that cholinergic stimulation of 
the SN is mediated by the DA-containing neurones of the SNPC, this has 
never previously been demonstrated behaviourally. It is possible that 
cholinergic agonists injected into the SN are in fact effecting other nigral 
efferents, for example the nigrotectal or nigrothalamic pathways. The 
nigrotectal pathway has been demonstrated by Redgrave et al. (1980) to 
have a role in the mediation of the oral stereotypies induced by 
apomorphine. Furthermore, although Winn and Redgrave (1979) 
concluded that the stimulatory effect on eating of intranigral carbachol 
was inversely proportional to the distance of the injection site from the 
SNPC, the possibility cannot be excluded that the effects of intranigral 
carbachol may be in fact due to its diffusion to the VTA. The DA- 
containing neurones of the VTA increase firing in response to muscarinic
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(Lacey et al. 1990) and nicotinic (Greenhoff et al 1986) agonists and has 
been associated with the control of eating (Koob et al 1978).
This experiment will attempt to demonstrate that increased feeding of a 
palatable food to which the rat has been pre-exposed by injection of 
carbachol into the SN can be blocked by a 6-OHDA lesion of the 
ascending DA-containing neurones of the SNPC. Rats will receive 
unilateral injections of carbachol and saline as previously described before 
and after a unilateral 6-OHDA lesion injected into the medial forebrain 
bundle as it passes through the LHA. This is preferable to trying to 
destroy the DA-containing cell bodies at source in the SN which has been 
less successful (Parker, Rugg and Winn, unpublished observations). 
Using a unilateral rather than bilateral study allows use of the 
unmanipulated hemisphere as a useful control for measurement of brain 
amines and also avoids the possible difficulties of interpretation associated 
with a bilateral 6-OHDA lesion that causes aphagia and adipsia if the 
depletion is severe enough (Ungerstedt 1971).
Methods
Animals
22 rats with mean body weight at the time of surgery 290.8 g (±  8.65 
SE) were used.
Stereotaxic surgery
Rats were anaesthetized with Avertin and placed in a stereotaxic frame 
in the orientation of level skull. The rats were implanted unilaterally with 
guide cannulae terminating above the anterior SN and the LHA. The 
LHA cannula allowed the subsequent injection with 6-OHDA or vehicle 
solution to the nigrostriatal DA neurones known to pass through this site.
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Intracranial drug administration
During each test session each rat received a microinjection into the SN 
of 0.5 /ig/0.5 pX carbachol or the vehicle solution saline.
Test procedure
Rats were habituated to the test procedure until they showed consecutive 
increase in spaghetti consumption. Rats were allowed access to spaghetti 
and tap water for 60 min before and after microinjection.
6-OHDA lesion
After each animal had been tested in response to both carbachol and 
saline, unilateral lesions were made by microinjecting 6-OHDA or the 
vehicle solution ascorbic saline into the LHA. Each animal was pre­
treated at least 30 min before with i.p. injections of pargyline and DMI.
14 rats received 1.0 pi of an 8.0 mg.ml’  ^ solution of 6-OHDA 
(calculated as free base) dissolved in 0.1 mg.ml'^ ascorbic saline, 8 rats 
received the vehicle solution alone. Rats were unanaesthetised for this 
procedure and microinjected as described in chapter 3 except the cannulae 
left in situ for 120 sec. The rats were left for 10 days for the neurotoxin 
to take effect then retested with carbachol and saline as before.
Histological and biochemical analysis 
Rats were killed by stunning and decapitation. The brains were removed 4
onto ice where left and right CP and NAcc were dissected, wrapped in 
foil, placed in dry ice and stored at -22^0. The remainder of the brain 
was post-fixed for further histological analysis as described in chapter 3.
The concentrations of the neurotransmitters DA and 5-HT, and their 
metabolites DOPAC, HVA and 5-HIAA were determined from the CP 
and NAcc samples using HPLC. The method used was a modification of 
that developed by Mayer et al. (1983). A homogenising solution of 0.1 M
105
4
1 tPerchloric acid containing approximately 0.25 pmols.ul'^ 3,4- 1
Dihydroxybenzylamine (the external standard) was added to the tissue 
samples which were then given 10 to 15 bursts with a sonic probe (
'Soniprobe', Lucas Dawes Ultrasonics) on a 50% cycle. The homogenate |
was placed in a Beckman Microfuge E for 30 sec then filtered through a î
0.45 pm nylon 'acrodisc' (Gelman Sciences). The samples were then 
injected into a BAS 400 Liquid Chromatograph fitted with a 10 cm 
cartridge packed with 3 pm ODS2 spherisorb (Capital HPLC Specialists).
The eluants were detected using a BAS amperometric detector (LC-4B), 
fitted with a glassy carbon working electrode maintained at 4-0.9 V. The 
biogenic amines were eluted with mobile phase containing 3% 
acetonitrile, 1.5% tetrahydrofluran, and 0.03% 1-octane sulphonic acid in 
150 mM monochloroacetic acid pH 3.0 at a rate of 1 ml.min"^.
Statistical analysis
The feeding and HPLC data were analysed using ANOVA, followed by 
Tukey's method for multiple comparisons where appropriate. The data 
were analysed without transformation.
Results
Histology
Cannula placements were verified post-mortem and Figure 18 presents 
representative sections showing these. Following histological 
examination, one rat were found to have misplaced cannulae (in the 
ventroposteromedial thalamic nucleus) and was therefore discarded from 
the behavioural analyses. Two of the 8 control animals developed a 
gastric pathology ('bloat', in response to the surgical anaesthetic) and 
were destroyed.
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Figure 18: Representative sections showing nigral cannulae
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Eating behaviour
Figure 19 shows the mean amounts of dry spaghetti consumed in 60 min 
following microinjection of carbachol or saline to SN, before and after a 
lesion in the LHA with 6-OHDA or vehicle solution. There were 
significant main effects of drug (saline or carbachol) ( F - 32.94, 1,14
p  <0.001), but not lesion group (6-OHDA or sham) (F=0.26, ^1 ,14) or 
session (pre- or post-lesion) (F—2.62, d f  1,14). However the three way 
interaction drug x lesion x session was significant (F—7.70, 1,14
/i<0.03). Post-hoc analysis revealed significant differences between 
carbachol and saline before lesion in both groups (6-OHDA /?<0.01, 
sham /?<0.05) but only in the sham group post-lesion (sham p<0.05). 
There was a significant difference in consumption to carbachol before and 
after lesion in the 6-OHDA group (p<0.01), but no difference in the 
sham group. There was no significant difference in feeding to saline in 
either group before or after lesion. In summary, carbachol increased 
eating compared to saline before and after the sham lesion  ^ but the eating 
to carbachol was reduced to saline level by lesion with 6-OHDA.
HPLC analysis
The concentrations of DA, 5-HT, and their main metabolites in the CP 
and NAcc, are shown in Table 1 as a percentage of the concentrations 
found in the unmanipulated hemisphere. There was a significant effect of 
lesion group on DA levels in the CP ( F - 11.21, d f 1,16 p < 0.005) but 
not in the NAcc (F=l,28, d f  1,16). Similarly, there was an effect of 
lesion group on levels of DOPAC (F=9.79, df 1,16 p < 0.007) and HVA 
(F=5.14, d f 1,16 p<0.04) in the CP, but not in the NAcc (DOPAC: 
F=0.43, d fl,\6 \  HVA: F —4.32, d f \ , \6 ) .  Lesion group had no effect 
on levels of 5-HT or 5-HIAA in the CP (F=1.23, # 1 ,1 6 ; F=1.53, d f
1,16) or the NAcc (F=1.23, # 1 ,1 6 ; F=0.21, #1 ,16).
. ...... . '.r'! W,
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Figure 19: Mean amounts o f dry spaghetti consumed in 60 min following 
injection o f carbachol or saline, before and after a 6-OHDA or sham 
lesion o f nigrostriatal DA neurones. Variance (SE) was always less than 
11.92% o f the mean. (* indicates p<0.05 o f carbachol and saline being 
the same manipulation on this measure)
gms food consum ed
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Some measures of the turnover of DA and 5-HT were possible by 
calculating the ratio of neurotransmitter to metabolite present in the 
tissues. Table 1 shows the ratios of DA:DOPAC, DA:HVA and 5-HT:5- 
HIAA in the CP and NAcc as a percentage of the ratios found in the 
unmanipulated hemisphere. There was a significant effect of lesion group 
on the ratio of DA:DOPAC in the CP (F= 10.96, # 1 ,1 6  p < 0.005) but 
not in the NAcc (F—1.05, #  1,16). There was no effect on the ratio of 
DA:HVA in the CP (F=3.50, # 1 ,1 6 ) or the NAcc (F=2.01, # 1 ,1 6 ). 
The ratio of 5-HT:5-HIAA was also unaffected in the CP (F= 0.19, #
1,16) and the NAcc (F==1.14, #1 ,16 ). Table 2 shows the mean levels of 
DA, 5-HT and their metabolites as ng.mg"^ of wet weight tissue in the 
CP and NAcc of the un manipulated hemispheres of both lesion groups. In 
summary these data show a significant decrease in concentration of DA 
and its metabolites as a percentage of their unmanipulated hemispheres in 
the CP of the 6-OHDA lesion rats as compared to controls, but not in the 
NAcc. Furthermore, there is a significant increase in turnover of DA to 
DOPAC in the CP but not the NAcc. Levels of HVA, 5-HIAA and their 
ratio were not affected in the CP or the NAcc.
Î
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Table 1: Mean (±.SE) levels o f DA, 5-HT, their main metabolites, and 
ratios o f monoamines to metabolites in the CP and NAcc o f 6-OHDA and 
sham-lesioned rats calculated as percentage o f unmanipulated 
hemisphere. (* indicates p  <0.05 o f lesion and control being the same 
population on that measure)
Caudate-putamen Nucleus accumbens
Lesion Control Lesion Control
DA 50.03* 96.35 70.02 89.58
±9.87 ±7.54 ±13.1 ±6.30
DOPAC 49.34* 95.45 80.84 92.04
±11.0 ±6.12 ±12.66 ±7.60
HVA 63.98* 100,58 77.83 112.11
±10.34 ±12.01 ±12.38 ±7.34
DA.DOPAC 50.72* 96.24 72.33 89.71
±9.84 ±7.43 ±12.85 ±6.05
DA:HVA 70.92 103.62 101.54 82.24
±9.66 ±15.78 ±9.96 ±8.56
5-HT 85.12 103.59 81.00 94.26
±12.30 ±7.41 ±14.76 ±6.84
5-HIAA 80.76 99.93 103.56 111.64
±11.76 ±3.43 ±10.32 ±14.79
5-HT:5-HIAA 90.57 97.06 72.09 95.26
±10.80 ±7.13 ±12.43 ±18.99
I l l
Table 2: Mean (+SE) amounts (ng.mg"^ wet weight tissue) o f DA, 5-HT 
and metabolites in CP and NAcc o f unmanipulated hemispheres o f  both 
lesion groups
DA
DOPAC
HVA
5-HT
5-HIAA
Caudate-putamen
14.01
±1.30
1.81
±0.26
0.69
±0.04
0.73
±0.09
0.71
±0.07
Nucleus accumbens 
9.78 
±1.05
1.85
±0.31
0.69
±0.06
1.21
±0.17
0.91
±0.13
iK
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Discussion
Increased feeding to palatable food following cholinergic stimulation of 
the SN was abolished by a unilateral 6-OHDA lesion of the ascending 
NSP DA neurones. The lesion caused a significant depletion of DA from 
the CP but not the NAcc. This suggests that it is nigrostriatal and not 
mesoaccumbens DA that is mediating the effects of cholinergic 
stimulation of the SN and furthermore that it is indeed the DA-containing 
neurones of the SNPC that are being stimulated rather than the source of 
the mesoaccumbens DA, the neighbouring VTA.
The depletion of DA from the CP was significant, but not total. The 
increased feeding to carbachol was abolished by reducing the DA content 
of CP tissue to 50% of the CP of the unmanipulated hemisphere. Such a 
level of depletion is known to promote weak rotation in response to 
amphetamine but much higher depletions of >90% are required to 
produce rotation to the direct agonist apomorphine (Hefti et al. 1980).
This would suggest that a lesion of the scale reported here would reduce 
the ability of amphetamine to promote release of DA from terminals in 
the CP, but would not effect the post-synaptic sensitivity to DA, The 
present data suggest that significant behavioural effects can be observed 
with DA loss of only 50%, a level of loss not associated with significant 
compensatory post-synaptic changes (Marshall and Ungerstedt 1977).
HPLC analysis revealed that not only were the levels of DA and its main 
metabolite DOPAC reduced in the CP of the lesion group animals, but 
the ratio of DA:DOPAC was also reduced. This suggests that the 
turnover of DA in the CP was increased as a result of the lesion. This is 
consistent with the scheme proposed by Zigmond (1989, see Nigrostriatal 
DA and behaviour) of how partial recovery of function may occur 
following a partial loss of DA innervation of an area. The most |'I-4
d
parsimonious explanation is that the DA neurones have increased their 
synthesis and release of DA from a reduced number of DA terminals such 
that the turnover of existing DA is increased. Clearly though, this 
increase is not sufficient to mask the effects of the lesion on the mediation 
of cholinergic stimulation by the NSP DA.
The depletion of NSP DA had no obvious effects on the normal 
behaviour of the animals. There was no obvious change in the ability of 
the animals to locomotor, eat or drink, as evinced by the lack of change 
in feeding to saline before and after the lesion. What was lost after the 
lesion was the increase in eating produced by intranigral carbachol. 
Previous studies have suggested that NSP DA is associated with the 
initiation of activity (Carli et al. 1985, Chiodo et al. 1979, 1980). It may 
be that intranigral cholinergic stimulation exerts its effects by releasing 
DA which in turn enhances the probability of certain behavioural 
procedures being initiated.
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8 Conditioned reinforcement and cholinergic stimulation of midbrain 
DA systems
Introduction
Although the previous experiments have addressed the neuroanatomical 
and pharmacological, they do not address the psychological question of 
how cholinergic stimulation of the SN affects behaviour.
Mesolimbic DA has been intensely investigated with regard to its role in 
the reinforcement of behaviours. It is thought to be the site of action for 
several drugs of abuse such as amphetamine which releases DA from 
terminals within the NAcc, and cocaine which blocks the re-uptake of DA 
into terminals thus prolonging its action (Koob 1992). Systemic 
administration of nicotine causes increased DA efflux in the NAcc, but 
not the CP (Brazell et al. 1990).
Subjects will increase responding for a previously neutral stimuli if 
repeatedly associated with a primary reinforcer, Taylor and Robbins 
(1984) demonstrated increased responding for conditioned reinforcement 
following administration of the dopamine agonist amphetamine into the 
NAcc, but not the CP. Such studies suggest that reinforcement is 
mediated by mesolimbic rather than nigrostriatal DA. Similar studies 
using injections of amphetamine into a number of striatal sites have 
produced ambiguous results (Kelley and Delfs 1990). Infusions of 
substance P and other peptides into the VTA produced increased DA 
efflux of ~50%, stimulating locomotion but not increased responding for 
conditioned reinforcement (Kelley et al. 1985, Kelley and Delfs 1991).
There is evidence for a cholinergic innervation of the VTA and the 
neighbouring SNPC derived from cholinergic neurones in the pons: the 
Ch5 cell group in the PPTg and possibly the Ch6 cell group in the
-  "  --- -- " ' : \  . . . .
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LDTN. There is an increasing literature on the cholinergic control of 
SNPC dopamine neurones which suggests a role in the potentiation of 
behaviours for which there is a pre-existing tendency to perform but a 
low current frequency (Winn 1991). There is pharmacological evidence 
for the presence of nicotinic receptors and electrophysiological evidence I
for the presence of muscarinic receptors on both SNPC and VTA DA .4
neurones (Clarke and Pert 1985; Lacey et al. 1990, resp.). , I
Administration of nicotine to the SNPC increases DA efflux in the î
• Icaudate-putamen (Blaha and Winn, In press) and increases firing rate of J
DA neurones innervating the NAcc, respectively (Grenhoff et al. 1986). Ij
âSuch stimulation can also be achieved by blocking the degradation, and ^
thus prolonging the stimulatory action, of endogenous ACh in the SNPC 4
(Blaha and Winn, In press; chapter 4). Given the ability of cholinergic |
terminals from pontine nuclei to stimulate DA release in the fbrebrain |
target sites of midbrain DA neurones, it is pertinent to ask whether the |
effects observed following administration of dopaminergic agonists into I
striatal areas can be replicated by stimulating DA efflux with cholinergic :|
agonists microinjected to the cell bodies of dopamine neurones in the 
midbrain. Therefore this study will examine and compare the effects on I
responding in a conditioned reinforcement paradigm of cholinergic j
stimulation of VTA or SNPC. Given the results of previous studies using |
DA agonists injected into the CP and NAcc it is predicted that cholinergic j
stimulation of the VTA, but not the SN, will increase responding for 4
conditioned reinforcement. J
Methods 
Animals
36 rats were used. To maintain the animals at 85% of free-feeding body 
weight, approximately 12 g of food (SDS maintenance diet no.l chow
'. 4 !
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pellets) were given at least one hour after testing. Mean body weight at 
the time of surgery was 307.8 g (SE = 2.47).
Stereotaxic surgery
Rats were anaesthetized with xylazine and ketamine and placed in a 
stereotaxic frame in the orientation of De Groot. The rats were implanted 
bilaterally with guide cannulae terminating above the anterior SN or 
VTA.
Intracranial drug administration
During each test session each rat received a bilateral microinjection to 
the SN or VTA. The rats received a cholinergic cocktail containing the 
following doses of carbachol and nicotine: 0 + 0, 0.1 ftg + 0.055 /ug,
0.1 /tg + 0.1 /ig, 0.1 ^g +  0.25 ftg. Previous experiments (Chapter 6) 
have shown that these doses of cholinergic agonists have reliable 
stimulating effects in a free-feeding task.
Habituation and training 
Following recovery from surgery, rats were habituated to the double- 
lever operant chamber over two 10 min sessions. In these habituation 
sessions the house lights were off, the food tray panel light on and 12 
pellets (45 mg Dustless Precision Pellets, BioServ) were available in the |ifood tray. |
In the training phase the animals were trained to associate the dispensing 
of food into the food tray with a preceding compound stimulus. The 
compound stimulus consisted of; the house light going off, the food tray 
panel light coming on, and the auditory click of the food dispenser. The 
presentation of the stimulus followed by the dispensing of a food pellet 
was on a random-time schedule beginning with a random presentation 
time between 8 and 12 sec. Pushing open the food tray panel 
prematurely, i.e. before the compound stimulus presentation, was 
'punished' by a 3-second 'time-out' before returning to the random-time
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schedule of stimulus-fbod presentation; punishment was not cumulative.
When subjects performed correctly (pressing the food tray panel only |
following the presentation of the compound stimulus) on at least 90% of 
the trials presented within a session, the random time schedule was 
increased by 5 sec. Each training session was 30 min in length and was 
repeated daily until the animals achieved criterion at a random time 
schedule between 23 and 27 seconds. For the rest of the experiment, there 
were no longer food pellets present in the food hopper.
One session was run for each animal where responding on one lever
resulted in the presentation of the compound stimulus which henceforth
will be referred to as the conditioned reinforcer lever (CR lever) but no
food pellet. Responding on the other lever resulted in no programmed
response (NCR lever, no conditioned reinforcer). Ascription of which
lever (left or right) should be the CR lever was made as a function of
counterbalancing equal L and R for the group and equal responding on L
and R levers on the last training session. The session lasted until 10
correct responses (pressing the CR lever) were recorded.
Testing
24 h after the final training session, the rats began a series of 4 test 
sessions, separated from, each other by 48 h. Each animal received 
bilateral microinjections through the chronic cannulae before being placed 
in the operant chamber. The order of testing was counterbalanced for 
group and site. Responses on the CR and NCR levers and food tray panel 
presses were recorded for 30 min.
Statistical analysis
Responses on the CR and NCR levers were analysed by analysis of 
variance using site (SNPC and VTA), lever (CR lever and NCR lever) 
and dose (saline and three doses of drug) as main effects. Food tray panel I
pushes were analysed similarly for effects of site and dose. The data and
i
analysis are presented without transformation, but analysis of the data 
with a square-root transformation produced similar results. Post-hoc 
analysis was made with Newman-Keuls test for multiple comparisons.
Results
Histology
Cannula placements were verified post-mortem and Figure 20 presents 
representative sections showing these. Following histological 
examination, 16 rats were found to have bilateral injection sites in SNPC 
and 16 had bilateral sites in VTA. Three animals had injection sites dorsal 
to their target, and 1 animal had an ambiguous placement that may have 
effected SNPC or VTA neurones. These 4 rats were excluded from all 
analyses.
Responding for conditioned reinforcement
All of the animals achieved a criterion of pressing the NCR lever on less 
than 10% of trials. The animals took 24 training sessions to achieve this 
criterion. Analysis of responding over 30 min following microinjection 
revealed a main effect of lever (F=7.82 4^= 1,30 /)<0.01) but no effect 
of site (F=0.11 4T=1,30), dose (F—OAl df—3.90) and no interactions 
(lever x site: F -0 .36  df~1,30; dose x site: F=0.54 df—3^90; lever x 
dose: F=0.29 df-3,90; site x lever x dose: F=0.29 df=3,90). Analysis 
of panel pushing over the same time period revealed a significant main 
effect of dose (F—3.81 df—3^90 p<0.02) but no main effect of site 
(F=0.36 df=lj30) and no site x dose interaction (F=0.65 (ÿ*=3,90). 
Post-hoc analysis of panel pushing revealed significant differences 
between the saline condition and 0.1 fig nicotine +  0.55 pg carbachol
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Figure 20: Representative sections showing SNPC ( 0  ), VTA ( ^  ) and 
misplaced ( M ) cannulae. The placements o f cannulae are shown here 
unilaterally for clarity, but represent bilateral infection sites. Misplaced 
cannulae were either outwith the SNPC and VTA or ambiguous in their 
placement
ÿ 0
; ...
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and between saline and 0.1 nicotine + 0.25 /xg carbachol (both 
j9<0.05).
An examination of the raw data for panel-pushing (Table 3) suggested 
that panel pushing in response to cholinergic stimulation might vary 
dependent on the baseline response to saline. As the ranking of 
responding shows, there was no effect of site on baseline responding. The 
Pearson correlation coefficient was calculated comparing panel pushing to 
saline with the increase in panel pushing to the cholinergic cocktail. This 
was calculated as the mean of the three doses minus the response to 
saline. There was a correlation of r=-.64, with a statistical significance 
of/? <0.001 (Figure 21).
Figure 21: Scatterplot o f panel pushing to saline vs increase in panel 
pushing to cholinergic stimulation (mean o f three doses minus saline).
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Baseline Panel Pushing
Given rate-dependency of panel pressing, the rats were divided into low 
and high baseline groups using a median-split (Figure 22). The low 
group, but not the high group, showed dose-dependent increased panel 
pressing (F=7.01 d f  3,45 p<0.001, F=.62 cÿ" 3,39 resp.). Post hoc
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Table 3: Panel pressing following bilateral microinjection o f cholinergic 
cocktail into SNPC or VTA (doses o f carbachol +  nicotine in 0.5 p/ 
saline) ranked by response to saline measured over 30 min post-injection
Doses of Carbachol 0 0.1 0.1 0.1 pgand Nicotine in saline 0 0.055 0.1 0.25 pg
VTA 5 26 13 23
VTA 5 12 14 16
SNPC 9 28 31 29
VTA 9 14 13 14
VTA 11 52 25 17
VTA 13 120 42 89
SNPC 13 49 13 46
SNPC 14 18 18 5
SNPC 14 41 19 32
SNPC 16 30 43 31
VTA 16 38 17 13
SNPC 16 38 47 88
SNPC 17 28 30 11
SNPC 18 56 25 51
SNPC 18 19 37 36
VTA 19 24 30 21
VTA 19 21 40 21
VTA 21 88 81 103
VTA 23 40 30 31
VTA 23 5 22 25
SNPC 26 45 57 79
SNPC 31 33 11 32
SNPC 35 61 52 50
VTA 35 51 28 95
VTA 36 33 13 38
SNPC 41 40 71 42
SNPC 41 24 27 60
SNPC 43 48 20 35
VTA 43 24 22 4
VTA 58 34 25 3
SNPC 65 66 31 65
VTA 88 53 47 17
"'-#1
122
analysis of panel pressing in the low group revealed saline to be 
significantly lower than all three doses of cholinergic cocktail (all 
p<0.01). The lever pressing raw data was then re-analysed (ANOVA) if
with main effects: site (SNPC and VTA); baseline panel pressing {low 
and high)\ lever (CR and NCR); and dose (saline and three doses of 
cholinergic cocktail). There was no main effect of site (F=.12 d f 1,28), 
baseline panel-pressing group (F=.86 d f  1,28) or dose (F=.48 4^3,84) 
but there was a significant effect of lever (F=9.20 d f  1,28 p <  0.005), a 
panel-pressing group x dose interaction (F—5.02 4^3,84 p<0.03) and a 
panel-pressing group x lever x dose interaction (F=2.86 d f 3,84 
p<0.05). No other interactions were significant.
Post-hoc analysis revealed higher responding on both levers in response 
to saline in the high baseline panel-pressing than in the low panel-pressing 
group (p<0.01). Post-hoc analysis of the three-way interaction revealed 
higher responding on the CR lever to 0.1 pg carbachol + O.l pg nicotine 
than to saline in the low baseline panel-pressing group (p<0.01).
Responding to CR lever in the high baseline panel-pressing group was 
significantly less in response to 0.1 pg carbachol + 0.1 /<g nicotine than 
to saline (p<0.01). Responding was also significantly higher on the CR 
than the NCR lever in response to saline in the high baseline panel- 
pressing group (p<0.05).
— li :— ^  V, , --f-, V  ■■■ ■ ■ ■■■— Ï,, - - J ' - . .
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Figure 22: Mean (±.SE) panel pushes, CR and NCR lever presses in 30 
min following bilateral microinjection o f doses o f carbachol +  nicotine 
into the VTA and SNPC (dota collapsed across site) in low and high 
baseline panel pressing groups, (* significant effect o f dose p  < 0.05)
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Low baseline panel pressing animals showed increased panel pushing, 
and increased CR but not NCR lever pressing. They responded to the
«  - - - -__________-I 11-11 I," I-'-______'■ - ■ . .. .T.,'. ,  .. '
■I
Discussion
Cholinergic stimulation of midbrain DA neurones increased responding 
for conditioned reinforcement in animals with a low baseline rate of panel #
pressing. The rats with a high baseline rate of panel pressing showed a 
higher baseline rate of CR than NCR lever pressing but no increased CR 
responding following cholinergic stimulation. This suggests that learning 
not to press the hopper-panel is a better predictor of increased responding 
for conditioned reinforcement following cholinergic stimulation than 
baseline CR lever responding.
Rats with a high baseline rate of panel pressing showed no effect of dose 
on responding to the panel, while rats with a low baseline rate showed 
increased panel pressing following cholinergic stimulation. It could be 
suggested that this is due to a ceiling effect. However, it is unlikely that 
there would be such a strong correlation between baseline panel-pressing 
and increase in panel pressing following cholinergic stimulation. The 
decrease in responding on the CR lever with no difference in responding 
on the NCR lever also argue that we are observing an interesting effect 
rather than a non-specific effect on general behavioural responding. That 
low baseline panel pressing rats increase their CR lever pressing while 
high baseline panel pressing rats decreased their responding is analagous 4
to behavioural effects seen before in manipulations of midbrain DA 
systems. Winn et al. (1983) observed that stimulation of increased feeding 
behaviour was dependent on the level of feeding prior to the injection.
Such rate-dependency of effects of manipulating DA systems on 
behaviour has been more fully described by Lyon and Robbins (1975) in 
their investigation of the central effects of amphetamine.
%
125
conditioned reinforcer and the site of the primary reinforcer. One 
interpretation is that cholinergic stimulation has reinstated panel pressing, 
widening the behavioural repertoire to include behaviour that had 
previously been reinforcing. That the increase in panel pressing occurred 
in conjunction with an increase in CR lever responses suggests increased 
cholinergic stimulation of midbrain DA-containing neurones has 
influenced behavioural selection within a learnt response set, rather than 
caused a dissociation of the CR lever with reinforcement.
The experimental hypothesis that stimulation of the VTA but not the 
SNPC would increase responding for conditioned reinforcement was not 
supported by this experiment. Injections of cholinergic agonists produced 
no difference between the two sites. Both sites receive cholinergic 
innervation from the pons and respond by increasing the activity of DA- 
containing neurones projecting to their respective striatal sites. However, 
previous studies injecting DA agonists to the NAcc and CP have ij
associated increased responding for conditioned reinforcement with 
mesolimbic but not nigrostriatal DA (Taylor and Robbins 1984). It is an 
obvious prediction to make that because direct manipulation of different 
striatal sites produces different behavioural effects, then stimulation of the 
sources of the DA innervation of these structures - the SNPC and the 
VTA - must also have different effects. However our results suggest that 
cholinergic stimulation of the SNPC and VTA produces no observable 
differences between sites in a conditioned reinforcement paradigm. There 
is evidence available that supports our data. Electrophysiological studies 
suggest that midbrain DA neurones in the monkey SNPC and VTA 
responded in a similar fashion in a conditioned reinforcement paradigm 
similar to that described in this paper (Ljungberg et al. 1992).
Furthermore, Lacey et al. (1990) found that rat VTA and SNPC neurones
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responded similarly to stimulation with Ml muscarinic cholinergic 
stimulation. As both sites receive cholinergic innervation from the pons, 
and this innervation is mediated at least in part by the same receptor sub- 
types, it is plausible that both mesencephalic sites are receiving and 
responding similarly to the same information. It could be that the results 
of studies using direct stimulation of the striatal sites reflect differences in 
the topographical innervation of the NAcc and the CP and the 
heterogeneity of DA receptor sub-type distribution in the striatum rather 
than a functional difference.
Administration of the peptide substance P to the VTA produced a 
statistically significant increase in responding on both the CR and NCR 
lever, suggesting a non-specific stimulation of motor output rather than a 
potentiation of responding for conditioned reinforcement (Kelley and 
Delfs 1991). However, the results of the present study following 
cholinergic stimulation demonstrate a dose-dependent increase in panel- 
pushing and increased responding on the CR but not NCR lever in low 
baseline panel pushing rats. Although the increase in responding for 
conditioned reinforcement was significant, it is not as strong as that 
produced by intra-NAcc amphetamine. This may be due to differences in 
levels of DA-ergic stimulation produced. In the present study DA efflux 
is stimulated by increasing the activity of midbrain DA-containing 
neurones to release DA within the physiological limits of normal neuronal 
activity. It has been suggested that increased responding for conditioned 
reinforcement using intra-NAcc amphetamine depends on massively 
increased efflux levels of DA compared to baseline (Hernandez and 
Hoebel 1988).
Increased DA efflux in the striatum has been interpreted as playing a 
variety of roles associated with a broad range of activities. These data fit 
well with the proposal by Robbins and Brown (1990) that one, if not the
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major function, of the CP is to define a "response set". The spatio- 
temporal control of certain responses, that would necessarily be a subset 
of possible responses, will be reinforced by DA release in the CP. 
However, their discussion does not make explicit what effect DA release 
would have on the responses to a given situation. Ljungberg et al. (1992) 
described the firing of DA neurones as falling off with repetition of a 
task. He suggests that once learnt a task has less of an "expectation" 
component and becomes an automatic response. This would be in 
agreement with Robbins and Brown (1990) and the present experiment. 
To place this studies findings in the vernacular of Ljungberg et al., the 
rats expect to find food in the apparatus and DA neurones respond; they 
then learn that pressing a lever produces the presence of food in the 
hopper and DA neurones are still responding; over trials the behaviour 
becomes learnt and DA responding falls off with the lessening of an 
'expectation' component; finally, in the test session the cholinergic 
stimulation of DA neurones signals that this situation is one requiring 
'expectation'. However, the present studies results suggest this loosening 
of behavioural response to the situation only extends as far as behaviours 
that have some association with obtaining of food. Hence an increase in 
panel-pushing and no change in responding to the NCR lever. It might be 
expected that there would be a decrease in responding on the CR lever.
behavioural repertoire within a learnt response set, rather than an 
unlearning of the association of the CR lever with reinforcement.
That this is not the case supports the interpretation of an increase in i]
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9 Discussion
This thesis has demonstrated behaviourally a cholinergic influence on 
midbrain DA-containing neurones. Administration of exogenous nicotinic 
and muscarinic cholinergic agonists into the anterior substantia nigra 
elicited increases in the consumption of palatable food but not standard 
lab chow in pre-satiated rats. Furthermore, this effect was also produced 
by blocking the de-activation of endogenous ACh using the AChE 
inhibitor neostigmine.
Both muscarinic and nicotinic receptors are present on midbrain DA- 
containing neurones. Stimulation with agonists for either produced 
increased consumption of palatable food in pre-satiated rats. Addition of a 
behaviourally stimulating dose of carbachol to a range of doses of 
nicotine produced a significant increase in feeding compared to nicotine 
alone. Furthermore, the nicotinic stimulation still produced dose #
dependent effects at the elevated level of feeding produced by carbachol 
suggesting a true additivity of effects. This study demonstrated that ^
cholinergic stimulation of nicotinic and muscarinic receptors in the SN 
can produce a behavioural effect that is additive using a relatively coarse 
measure of behaviour. There is presumably a functional reason for having 
two sorts of cholinergic receptor in the SNPC, and indeed sub-types of 
muscarinic receptors. The effects mediated on the cell membrane by ACh 
at such sites need not necessarily always be additive. Although there is 
evidence for the presence of both types of receptor on DA-containing 
neurones of the SNPC and VTA, there is as yet no demonstration of (i) 
what proportion of neurones have nicotinic, muscarinic, and both types of 
receptor, (ii) how they relate on the somata and dendrites and (iii) how
"g
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the administration of specific agonists for each type effects the cholinergic 
stimulation at physiological and behavioural levels.
Although there was strong evidence for the effects of cholinergic 
stimulation of the SN being mediated by the DA-containing neurones of 
the SNPC, this had not previously been demonstrated directly. Increased 
consumption of palatable food elicited by cholinergic stimulation of the 
anterior SN was abolished by a selective 6-OHDA lesion of ascending 
DA containing neurones that significantly reduced DA concentration in 
the CP but left NAcc DA unaltered. Previous studies have described the 
need for near total depletions of CP DA levels for there to be obvious 
behavioural dysfunction in response to direct agonists, but unilateral 
lesions of the size described here will produce rotational behaviour in 
response to indirect DA agonist amphetamine (Hefti et al. 1980). The 
'50% depletion of CP DA levels was sufficient to attenuate the increase 
in feeding caused by cholinergic stimulation of the SN. This level of 
depletion in a unilateral preparation did not effect normal eating 
behaviour as there was no difference in consumption following saline 
injection between the 6-OHDA and sham lesion groups. It would appear 
that the brain, whether it be rat, monkey or human, can sustain large 
depletions of CP DA without obvious effect on behaviour. That there is 
no significant post-synaptic compensatory response to the loss of DA until 
it reaches the order of 90% seems incredible. However, if the role of 
striatal DA is to facilitate the processing of cortico-strio-pallido-thalamo- 
cortico-reticular outflow, it is easier to see how such a neurochemical 
deficit might not be behaviourally obvious.
The mesencephalic DA-containing neurones of the SNPC and VTA i
innervate the CP and the NAcc. Studies injecting DA agonists directly ;
!into these forebrain sites have shown increased responding for
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conditioned reinforcement from the NAcc but not the CP. Hence it was 
predicted that cholinergic stimulation of the VTA but not the SNPC 
would produce increased responding for conditioned reinforcement. 
Contrary to the experimental hypothesis, administration of cholinergic 
agonists to VTA or SN caused indistinguishable effects on responding in a 
conditioned reinforcement paradigm. Cholinergic stimulation of midbrain 
DA neurones increased responding for a conditioned reinforcer and 
reinstated responding at the primary reward source. Food was used as the 
primary reward associated with the previously neutral stimulus in the 
training phase of this experiment. However, in the test phase the rats 
were responding for the presentation of just the conditioned reinforcer. 
This study had shown that cholinergic stimulation of midbrain DA 
neurones can influence not only appetitive behaviour, but also the more 
abstract construct of responding for a reinforcing stimulus with the 
appetitive component removed.
There is still the question to be addressed of why cholinergic stimulation 
of the DA-containing neurones on the SNPC and VTA does not reflect 
the differences observed following administration of DA-ergic agonists 
into the CP and the NAcc. Gerfen's scheme (1992) of how cortico-strio- 
pallido-reticular connections relate (Figure 5) and Lowenstein's 
demonstration (1990) of consistently more DA terminals in the matrices 
than the patches of the CP and the NAcc - approximately 2 :1 - may give 
us a clue. It has been proposed by Gerfen (1989) that the patches of the 
dorsal striatum conveys "limbic" information - motivation, learning and 
memory - normally associated with the ventral striatum, and that the 
matrices of the ventral striatum conveys "non-limbic* information - motor 
control and sensorimotor integration - more normally associated with 
dorsal striatal function. Furthermore Gerfen proposes that the limbic
circuitry dominates in the ventral striatum, while the non-limbic circuitry 
dominates the dorsal striatum. Therefore direct administration of DA- 
ergic agonists into the NAcc will favour "limbic behaviour", while DA- 
ergic stimulation of the CP will favour "non-limbic behaviour". 
However, if as is suggested by Lowenstein et al. (1990) the innervation 
of the matrices is two-fold greater than that that of the patches in both the 
dorsal and ventral striatum, stimulation of DA efflux by stimulating the 
SNPC or VTA would similarly favour the "non-limbic" matrices (see 
Figure 23).
Figure 23: Proposed model o f DA-ergic innervation o f striatum to explain 
the difference in effect o f stimulation at striatal and midbrain sites
Dorsal striatum Ventral striatum
Limbic
Patches Non-limbicMatrices
SNPC
Non-limbicMatricesLimbicPatches
VTA
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Thus administering DA agonists directly into the striatum would reveal 
the dorso-ventral gradient of "non-limbic" and "limbic* striatal targets, 
while promotion of DA efflux from the midbrain cell bodies would effect 
both the "non-limbic" matrices and "limbic" patches in a proportion that
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consistently favours the "non-limbic" matrices. This could explain why 
cholinergic stimulation of the midbrain DA systems produced no site 
difference between the VTA and SNPC. It would also explain why the 
increase in responding for CRF was present, but not as clear as can be 
produced by intra-NAcc injections.
Leonard and Llinas (1990) have described three types of neurones in the 
PPTg and LDTN on the basis of their electrophysiology, morphology and 
hodology. It appears that type H and possibly type III neurones are 
cholinergic and are candidates for providing the cholinergic influence on 
midbrain DA-containing neurones. Type II neurones were observed to 
display tonic firing patterns, while type III neurones are characterised as 
being able to display tonic or phasic firing patterns. Cholinergic neurones 
displaying a tonic firing pattern would be in keeping with the view of the 
PPTg maintaining a tonic influence over the brain as part of an ascending 
reticular activating system (Garcia-Rill 1991). However, the possibility 
that there are also type III neurones innervating the midbrain from the 
PPTg make it tempting to speculate as to the purpose of having both 
muscarinic and nicotinic cholinergic receptors on the membranes of 
midbrain DA-containing neurones. That a phasic cholinergic influence 
might be mediated by nicotinic receptors while a tonic influence is 
maintained by muscarinic receptors provides us with the possibility that 
separate populations of cholinergic neurones in the pons are effecting the 
activity of midbrain DA-containing neurones in a tonic and a phasic 
manner. However, as it stands the evidence seems to favour a 
predominantly tonic effect of cholinergic neurones on midbrain DA- 
containing neurones. How the sub-types of cholinergic receptors are 
distributed on the DA-containing neurones and the pattern of cholinergic 
innervation from the PPTg and LDTN are questions that we can expect to 
be answered with existing techniques.
Cholinergic control of midbrain DA-containing neurones determines the 
efflux of DA at the respective forebrain sites of the SNPC and the VTA. 
It is tentatively suggested on the basis of the experiments described here 
and previous studies that the DA efflux is playing a facilitatory role on 
the processing of information from the limbic cortex in the NAcc and 
sensory and motor cortex in the CP. In so doing DA efflux is gating the 
processing of inputs that are presumably competing for influence over the 
output stations of the basal ganglia, the GP and the SNPR.
Increased DA release in the CP following cholinergic stimulation of SN 
is causing increased behavioural activity in a manner dependent on certain 
behavioural antecedents and environmental cues. Schultz and his 
colleagues (Ljungberg et al. 1992) state that "DA neurones...respond to 
stimuli that have the capacity to elicit behavioral reactions...stimuli which 
do not elicit attention or particular behavioral reactions from the subject, 
do not activate DA neurons". Furthermore, Schultz found that DA 
neurons increased firing if these conditions were satisfied, even if the 
animal did not then respond.
There exist neurones in the CP that appear to fire in a manner consistent 
with the expectation of a sensory cue or behavioural act that the animal 
should expect to find rewarding (Hikosaka et al. 1989). These neurones 
do not fire in response to fixation of a point, nor do they fire to the 
presentation of an unexpected reward. Indeed in studies using conditioned 
association of a neutral stimulus with a primary reward, once the 
association is learnt, the neurone will fire to the preceding conditioned 
stimulus and not the primary reward. Other CP neurones will fire in 
response to a novel stimulus, but such a stimulus might well provoke the 
expectation of reward in an animal high up the food chain. Such novelty 
to a rodent might well provoke an expectation of being lunch rather than 
finding it.
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Behavioural responses have been observed following microinjections of 
cholinergic agonists into the SN. It might be predicted from the work of 
Hikosaka et al. (1989) and Ljungberg et al. (1992) that stimulation of DA 
firing in this way might elicit a behavioural response to any stimuli that 
might be presented to the animal. However, the experiments presented in 
this thesis show that this is not the case. It might be that a given stimulus 
must be ’plausible' as a target of behaviour. Whatever the construct is 
that guides the animals response or lack of response in a given situation, 
it does so such that an animal given no suitable or ’plausible’ behaviour to 
perform following cholinergic stimulation of NSP DA neurones will 
perform as if no stimulation has occurred. The animal displays no visible 
signs that might be interpreted as thwarting, no increased locomotion, 
exploring to find a suitable outlet for said stimulation. It appears that 
some process has simply ignored or suppressed the information contained 
by the increased efflux of DA into the CP. Furthermore, if we now 
accept Hikosaka*s views on caudate activity and Schultz's views on NSP 
DA firing, we might predict that stimulation of DA firing concomitant 
with the opportunity to perform a behaviour the animal would find 
rewarding should increase the probability of that behaviour being 
performed. If Schultz is correct, at a rat’s first exposure to palatable food 
the DA neurones will be firing, responding to a stimulus that has the 
capacity to elicit a behavioural reaction. Administration of cholinergic 
agonists at this point would be attempting to cause an increase in firing by 
pharmacological means in neurones that are already firing as a 
consequence of a behavioural stimulus. It is not clear whether such a 
manipulation should be able to increase the behavioural response of the 
animal in response to, say, a mildly stimulating behavioural stimulus.
So what is happening such that the neurones are able to be stimulated 
once the animal has been pre-exposed? Is it that the DA neurones have ,4
1stopped firing after the first exposure and that the cholinergic stimulation 
is now able to stimulate increased behaviour now that the behavioural 
stimulus itself has lost its ’attraction' ?.
If such a behaviour can be seen as the culmination of a drive saying;
Expect a reward 
and sensory feedback checking:
Is there a reward ? 
and if Schultz is correct in his description of DA neurones responding to 
stimuli that could be expected to be rewarding, the cholinergic stimulation 
of DA neurones would be predicted to have a re-rewarding effect on any 
stimulus that previously had been rewarding but was not at the time of 
administration of cholinergic agonist to the SN. This would fit what is 
observed in the studies described here.
Blaha and Winn (In press) have demonstrated an elevated efflux of 
striatal DA following microinjection of cholinergic agonists or 
anticholinesterases into the SNPC of an anaesthetised rat. The time course 
of the effect on striatal DA levels following neostigmine is of the order of 
four hours which is consistent with its duration of pharmacological effect 
(Taylor 1980). Efflux of DA in response to nicotine is still elevated far 
longer than this. Why is it then that the behavioural responses observed 
following microinjection of the same doses into unanaesthetised rats 
produce last at most an hour? If a rat is left in a cage with nothing to do, 
microinjection of cholinergic agonists into the mesencephalon will have 
no observable behavioural effect. It would appear that there is a sensory 
component that must be satisfied for behaviour to occur. If there is no 
plausible opportunity for behaviour, then nothing occurs. If the animal is 
in the presence of palatable food, palatable fluid or an opportunity to 
copulate then there is a plausible behaviour for the animal to engage in. 
Blaha and Winn’s measurement of DA efflux remained elevated for as
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long as the drug's duration of effect possibly because there would be no 
cortico-striato-pallido-mesencephalic feedback in the anaesthetised rat to 
inhibit the firing of the DA neurones.
Both the VTA and the SNPC receive cholinergic innervation from the %
pons and respond, in a conditioned reinforcement paradigm and 
electrophysiological studies, in a similar manner to cholinergic 
stimulation. Given that their target striatal structures have other afferents 
and efferents that are not the same it is understandable that direct 
stimulation of these structures will produce varying effects on behaviour.
But these results suggest that physiologically relevant activation of the 
DA-ergic afferents can produce the same effect on an appropriate 
behavioural test.
The innervation of these sites by pontine cholinergic neurones, although 
significant and clearly functionally important, is much smaller than the 
projection to various thalamic nuclei known to be involved in motor 
control, especially the ventrolateral thalamus (Lee et al. 1988). It could 
be that the cholinergic stimulation of the VTA and SNPC co-ordinates the 
activation of behaviour, with the execution being controlled by those 
areas of the thalamus receiving pontine efferents. Further research will 
characterise more fully how pontine cholinergic influence effects the 
relationship between the thalamus, the neocortex and the basal ganglia in 
the selection and control of behaviour.
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